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ABSTRACT 
 
NICOLE MARIE VINCENT JORDAN: Epigenetic Regulation of Epithelial-
Mesenchymal Transition in Epithelial Stem Cells and Triple Negative Breast Cancer 
(Under the direction of Gary L. Johnson, Ph.D.) 
 
 
Epithelial-mesenchymal transition (EMT) is a cellular program responsible for 
the conversion of stationary epithelial cells characterized by apical-basolateral 
polarity to motile mesenchymal cells with front-back end polarity. EMT drives the 
fundamental developmental processes of implantation, gastrulation and neural crest 
formation. This essential developmental program becomes reactivated during cancer 
progression to promote metastasis. These studies examine the molecular and 
epigenetic mechanisms responsible for the induction of EMT in several 
developmental epithelial stem cell models and Basal-like and Claudin-low breast 
cancer subtypes.  
Using trophoblast stem (TS) cells paused in EMT, we have defined the 
molecular and epigenetic mechanisms responsible for modulating the induction of 
EMT. Targeted inactivation of MAP3K4, knockdown of CBP, or overexpression of 
SNAI1 in TS cells induced intermediate EMT phenotypes. These TS cells exhibited 
epigenetic changes in the histone acetylation landscape that caused loss of 
epithelial maintenance while preserving self-renewal and multipotency. MAP3K4 
controls the activity of the histone acetyltransferase CBP, and acetylation of histone 
H2B by CBP is required to maintain the epithelial phenotype of TS cells. Combined 
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loss of MAP3K4/CBP activity represses expression of epithelial genes and causes 
TS cells to undergo EMT while maintaining self-renewal and multipotency. 
 A similar EMT phenotype and an EMT gene signature shared with TS cells in 
EMT were found in Claudin-low breast cancer cells with properties of EMT and 
stemness. Therefore, it was hypothesized that the upregulated genes within the 
intersecting EMT signature define a novel set of genes critical to the induction of 
EMT and maintenance of the mesenchymal phenotype in breast cancer cells. We 
designed an RNAi screen in the Claudin-low EpCAM(-) population of SUM149 and 
SUM229 Basal-like breast cancer cells to identify genes responsible for maintaining 
the mesenchymal phenotype. Using this RNAi screening strategy for EMT-regulatory 
genes, the chromatin-remodeling factor Smarcd3/Baf60c was identified as a novel 
epigenetic regulator controlling the induction of EMT. Expression of Smarcd3/Baf60c 
in human mammary epithelial cells promoted EMT in a Wnt5a-dependent manner. 
These results highlight a new mechanism of epigenetic regulation of EMT, whereby 
Smarcd3/Baf60c promotes loss of epithelial cell polarity and dissolution of cell-cell 
junctions through activation of non-canonical WNT signaling. 
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Chapter I 
 
Introduction 
 
Epithelial-Mesenchymal Transition 
Epithelial-mesenchymal transition (EMT) is a morphogenic cellular program, 
whereby stationary epithelial cells convert to a motile mesenchymal morphology. 
The initiation and subsequent completion of EMT occurs through the precise 
coordination of numerous molecular events, including activation of EMT-inducing 
transcription factors, altered expression of cell-surface proteins, reorganization of the 
actin cytoskeleton and enhanced invasive properties (Thiery et al, 2009). Epithelial 
cells exhibit an organized apical-basolateral polarity maintained by the precise 
arrangement of actin filaments and adhesive structures such as tight junctions, 
adherens junctions and desmosomes. Specialized adhesive molecules, such as 
cadherins, integrins and other cell-surface proteins, are essential for maintenance of 
the epithelial phenotype by stabilizing cell-cell contacts (Thiery & Sleeman, 2006). 
Inhibition of these adhesive structures, most important of which is E-cadherin, 
induces a morphological switch to the mesenchymal phenotype. Conversely, 
mesenchymal cells are characterized by a unique spindle morphology defined by a 
front-back end polarity and enhanced invasive potential (Hay, 2005; Kalluri & 
Weinberg, 2009). In addition to promoting cellular migration and invasion, the 
transient phenotypic changes associated with formation of the mesenchymal state 
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during EMT have been associated with the acquisition of stem-like properties (Mani 
et al, 2008). The intermediate stage of EMT, coined the metastable phenotype, 
describes the simultaneous existence of both epithelial and mesenchymal 
characteristics and is of great importance for understanding the cellular changes 
associated with progression of the EMT program and maintenance of stem cell-like 
properties (Lee, 2006). Due to the tremendous difficulty in capturing cells in the 
intermediate states of EMT, most studies have focused on the initiation or 
completion of EMT. In chapter three, I describe the development of multiple 
trophoblast stem (TS) cell models to examine the molecular and epigenetic 
mechanisms underlying the intermediate stages of EMT and the connections 
between EMT and stemness.  
 
Classifications of EMT 
EMT is essential for the proper formation of the body plan and differentiation 
of many tissues and organs during embryonic development (Yang & Weinberg, 
2008). During organ development, epithelia convert between epithelia and 
mesenchyme through multiple rounds of EMT and the reversible process 
mesenchymal-epithelial transition (MET) (Acloque et al, 2009). In adult tissue, the 
EMT program is reactivated during wound healing, organ fibrosis and tumor 
progression. EMTs are classified into three main categories based upon involvement 
in different biological processes (Figure 1.1) (Kalluri & Weinberg, 2009; Zeisberg & 
Neilson, 2009). Developmental EMTs constitute the first EMT subtype and include 
implantation, gastrulation and neural crest formation. Developmental EMT events 
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occur in a temporally controlled setting and contribute to embryonic morphogenesis 
and tissue remodeling during development. The second EMT subtype is associated 
with wound healing and tissue regeneration in adult tissue and occurs in response to 
inflammation. Persistent inflammatory signals produce continuous activation of EMT 
resulting in organ fibrosis. Organ fibrosis is commonly associated with inflammation 
of epithelia from the kidney, liver, lung and intestine and can ultimately lead to failure 
of these organs. The third EMT subtype occurs during cancer progression, whereby 
EMT in epithelial cancer cells produces cells with increased invasive capacity and 
promotes intravasation and dissemination of malignant cancer cells into the lumina 
of blood vessels.  
Although the three subtypes of EMT have seemingly diverse outcomes, a 
common set of molecular features underlies each EMT event. Critical developmental 
signaling pathways (i.e. WNT, Notch, Hedgehog and TGFβ) with demonstrated 
importance in promoting developmental EMT are reactivated in the generation of 
EMT-associated pathologies, including organ fibrosis and the metastatic spread of 
cancer (Figure 1.1) (Thiery & Sleeman, 2006; Kalluri, 2009; Timmerman, 2004; 
Zavadil et al, 2004; Zavadil & Böttinger, 2005). Due to the considerable overlap 
between signaling pathways that regulate both developmental EMT and EMT-
associated pathologies, it is important to examine developmental and cancer EMT in 
parallel. These parallel studies may increase our understanding of universal EMT 
regulatory mechanisms.  
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Trophoblasts and the First Developmental EMT Event 
 Implantation is the first developmental EMT event and is essential for proper 
placental development necessary to support a developing fetus. Failure of 
implantation prevents all successive EMT processes, such as gastrulation and 
neural crest formation (Rossant & Cross, 2001). During implantation, the epithelial 
trophoectoderm of the blastocyst undergoes EMT with changes in cell polarity, 
motility and adhesiveness (Figure 1.1). These changes in cell polarity are 
accompanied by extension of protrusive structures and loss of expression of the 
master-regulator of the epithelial phenotype E-cadherin, which are necessary for 
trophoblast invasion of the uterine epithelium. After implantation, the epithelial polar 
trophoectoderm overlying the inner cell mass of the blastocyst differentiates into 
specialized trophoblast lineages to form a functional placenta. In mouse, trophoblast 
stem cells in the polar trophoectoderm differentiate into three regions of the placenta 
including the labyrinth, which is comprised of syncytiotrophoblasts, the 
spongiotrophoblasts and the trophoblast giant cell layer. In humans, the epithelial 
trophoectoderm differentiates into an inner layer of proliferative cytotrophoblasts (i.e. 
trophoblast stem cells) and an outer layer of differentiated, multinucleated 
syncytiotrophoblasts. Invading trophoblasts generated through differentiation 
penetrate and remodel the maternal blood vessels, forming the chorionic villi. 
Considered the functional unit of the placenta, the chorionic villi provide a large 
surface area for nutrient exchange between mother and developing fetus. Formation 
of the chorionic villi, requiring extensive blood vessel remodeling, constitutes the 
second developmental EMT event (Gonzales et al, 1996; Pafilis et al, 2007; 
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Sutherland, 2003; Zhou et al, 1997b). Due to the functional importance of 
trophoblast stem (TS) cells to the first developmental EMT events, in chapter three, 
we examine TS cells during the progression of EMT. 
Pathologies Associated with Dysregulated Trophoblast EMT 
Precise regulation of trophoblast EMT is essential for successful implantation 
and placentation. Under normal conditions, the trophoblast invasive potential is 
restricted both temporally and spatially according to trophoblast differentiation 
signals. Several disease states are resultant from dysregulated trophoblast EMT. 
Two notable pathologies, preeclampsia and accreta, manifest as clinical outcomes 
directly linked to aberrant trophoblast invasion (Goldman-Wohl & Yagel, 2002). 
Preeclamsia is classically defined as an increase in blood pressure during 
pregnancy due to abnormally low blood flow into the placenta. At the molecular level, 
preeclamsia is the result of decreased or absent trophoblast invasion and 
remodeling of the maternal arteries (McMaster et al, 2004; Zhou et al, 1997a). The 
loss of trophoblast invasive potential has been connected to lack of adhesive 
molecules such as integrins and glycoproteins and to the increased production of 
extracellular matrix proteins such as collagens. As the disease state progresses, the 
invading trophoblasts are incapable of penetrating and remodeling the maternal 
spiral arteries, resulting in an immunological response against the invading 
trophoblasts and ultimately leading to damage and occlusion of the maternal 
arteries.  
Conversely, placenta accreta is defined as abnormal adherence of the 
placenta to the uterine epithelium resulting from excessive invasion of hyperinvasive 
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trophoblasts into the uterine wall. Trophoblasts at the maternal-placental interface 
have demonstrated increased invasive capacity. Rather than being more 
differentiated and syncytiotrophoblastic in nature, these trophoblasts resemble self-
renewing and highly proliferative cytotrophoblasts (i.e. trophoblast stem cells) in the 
early stages of implantation and placenta development (Khong, 2008; Perry et al, 
2009). Due to the similarity between invasive trophoblasts and malignant cancer 
cells, it is likely that similar regulatory paradigms persist between these EMT 
subtypes (Ferretti et al, 2006).  
 
Metastatic Progression of Breast Cancer and EMT 
Cancer metastasis is responsible for the majority of cancer related deaths, 
and EMT is the biological program linked to the cellular traits associated with the 
metastatic progression of cancer (Nguyen et al, 2009; Berx et al, 2007; Yilmaz & 
Christofori, 2009; Huber et al, 2005; Christiansen, 2006). During metastasis, 
epithelial cancer cells utilize the EMT program to detach from the primary tumor, 
invade the surrounding stroma, intravasate into blood vessels and disseminate to 
distant tissues. The reverse process MET is required for the metastatic colonization 
and proliferation of cancer cells at distant tissues, resulting in the formation of 
macroscopic metastases (Valastyan & Weinberg, 2011). By understanding the 
underlying molecular mechanisms contributing to EMT and the reverse process 
MET, new strategies can potentially be developed for the prevention and treatment 
of malignant breast cancer. 
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Breast cancer is classified into five intrinsic subtypes on the basis of gene 
expression profiling. These intrinsic subtypes, including Luminal A, Luminal B, 
HER2-enriched, Basal-like and Claudin-low, are predictive of treatment outcome 
(Perou et al, 2000; Sørlie et al, 2003; 2001; Prat & Perou, 2011). Clinically, Basal-
like and Claudin-low breast cancers are poor prognostic breast cancer subtypes, 
largely consisting of triple negative ER-, PR-negative and HER2-low invasive ductal 
carcinomas (TNBC). Patient prognosis with TNBC is poor due to the increased rates 
of recurrence, brain and lung metastasis and EMT-marker expression (Fulford et al, 
2007; Gaedcke et al, 2007; Banerjee, 2006; Rakha et al, 2008a). At the molecular 
level, Basal-like and Claudin-low breast cancer share similar expression patterns, 
such as low expression of luminal- and HER2-related genes. Whereas the Basal-like 
subtype is characterized by high expression of proliferation and basal/myoepithelial 
cell-specific genes, including cytokeratins 5/14/17, the Claudin-low subtype is 
characterized by high expression of mesenchymal- and stem cell-related genes and 
low expression of epithelial-specific and tight junctions genes, including claudins 
3/4/7 (Prat & Perou, 2011; Prat et al, 2010; Hennessy et al, 2009; Rakha et al, 
2008b; Taube et al, 2010). Functionally, Basal-like and Claudin-low breast cancer 
demonstrate increased rates of cellular migration and invasion. The aggressive 
metastatic properties of the Basal-like and Claudin-low intrinsic molecular subtypes 
of breast cancer make these subtypes important to study with respect to the EMT. In 
chapter four, I describe Basal-like breast cancer cell lines with Claudin-low features 
and examine the molecular and epigenetic mechanisms regulating EMT with respect 
to breast cancer. 
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Molecular Mechanisms of EMT  
Multiple reports demonstrate that the very same transcription factors (i.e. 
SNAI1, SNAI2, TWIST1), adhesive structures (i.e. aν-β-integrin family) and signaling 
pathways (i.e. Tgfβ, WNT, MAPK, integrin) controlling defined developmental EMT 
programs are also responsible for regulating tumor progression (Thiery & Sleeman, 
2006; Grünert et al, 2003). Loss of E-cadherin expression and gain of cellular 
invasiveness is central to the acquisition of EMT properties. Transcriptional and 
epigenetic repression of E-cadherin results in loss of E-cadherin at junctional 
complexes, destabilization of epithelial junctions and loss of epithelial cell apical-
basolateral polarity (Larue et al, 1994; Derksen et al, 2006). Subsequent to the loss 
of E-cadherin at cellular junctions, β-catenin relocalizes from the cytoplasm to the 
nucleus and activates WNT signaling pathways. In addition to WNT signaling, 
significant crosstalk exists between transforming growth factor β (TGFβ), mitogen 
activated protein kinase (MAPK) and β1-integrin signaling pathways to promote the 
morphological changes associated with EMT. 
Molecular Mechanisms of Trophoblast EMT 
 Trophoblast stem (TS) cells can be isolated from the trophoectoderm of the 
developing blastocyst and the extraembryonic ectoderm of the E6.5 conceptus 
(Rossant & Cross, 2001). Self-renewal in TS cells, defined as cell division with the 
maintenance of multipotency, is maintained in culture conditions by fibroblast growth 
factor 4 (FGF4) (Erlebacher et al, 2004; Tanaka, 1998). E-cadherin and cortical actin 
localize around the periphery of TS cell epithelial colonies and maintain the integrity 
of the epithelial colonies (Larue et al, 1994; Shih et al, 2002). Removal of FGF4 
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induces TS cell differentiation into different trophoblast lineages. Differentiating 
trophoblasts undergo an EMT involving downregulation of E-cadherin expression, 
loss of cortical actin with concomitant gain of filamentous actin and the acquisition of 
invasiveness (Abell et al, 2009). Since TS cell differentiation pathways are essential 
to EMT processes of implantation and placentation, the, in vitro, TS cell 
differentiation model induced by removal of FGF4 is highly useful for interrogating 
the connections between EMT and TS cell differentiation. 
 The genetically engineered mouse model with targeted inactivation of 
MAP3K4 (KI4), a kinase regulating c-Jun N-terminal kinase (JNK) and p38 MAPK 
pathways, exhibits defective decidualization, fetal growth restriction and implantation 
defects attributable to trophoblast hyperinvasion and dysregulated EMT (Abell et al, 
2005). When cultured in non-differentiating conditions in the presence of FGF4, 
TSKI4 cells demonstrate a 20-fold increase in invasion compared to wild-type 
trophoblast stem cells (TSWT cells). Furthermore, the acquisition of the mesenchymal 
phenotype in TSKI4 cells is demonstrated by several phenotypic and molecular 
changes, including loss of epithelial apical-basolateral polarity and a gain of 
mesenchymal front-back polarity with reduced levels of peripheral E-cadherin. 
Importantly, TSKI4 cells maintain self-renewal properties as demonstrated by 
expression of trophoblast stem cell markers CDX2 and ESRRβ at levels similar to 
TSWT cells (Abell et al, 2009; Niwa et al, 2005; Ralston & Rossant, 2008; Strumpf, 
2005). The simultaneous existence of stemness and EMT properties indicates that 
TSKI4 cells represent a metastable EMT state. Metastable EMT is defined as an 
intermediate stage in the progression of the EMT program, whereby cells express 
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attributes of both epithelial and mesenchymal phenotypes while simultaneously 
expressing stem cell markers (Lee, 2006). Due to the transient nature of the 
metastable phenotype, it is difficult to observe this intermediate stage during the 
progression of EMT. Using TSKI4 cells, we can examine the simultaneous 
maintenance of stemness and the acquisition of EMT properties that promote an 
unrestricted trophoblast invasive potential. During both development and the 
progression of cancer, hyperinvasion resulting from uncontrolled EMT signaling 
events can be detrimental to survival. Therefore, the TSKI4 cell model system in 
metastable EMT is a unique tool to define novel transcriptional and epigenetic 
reprogramming events and signaling pathways important for progression of the EMT 
program. 
Molecular Mechanisms of Breast Cancer EMT 
In recent years, evidence for the role of EMT in the metastatic progression of 
breast cancer has continued to build (Huber et al, 2005; Christiansen, 2006). For 
instance, loss of E-cadherin expression is a hallmark of metastatic carcinoma, and 
expression of the transcriptional repressor of E-cadherin SNAI1 correlates with poor 
survival rates. Additionally, SNAI1 expression levels are elevated at the invading 
front of tumors (Derksen et al, 2006; Moody et al, 2005; Yook et al, 2006). The 
controversy surrounding the role of EMT in cancer metastasis stems from the 
difficulty of directly following the progression of EMT during tumor formation. In 
support of the connection between EMT and cancer metastasis, both proteomic and 
multiphoton microscopy analysis demonstrate the conversion of epithelial breast 
tumor cells to circulating mammary tumor cells with a mesenchymal phenotype 
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(Bonnomet et al, 2010; Willipinski-Stapelfeldt, 2005; Wyckoff, 2004). Furthermore, 
the genetically-engineered pancreatic cancer mouse model with YFP-labeled 
pancreatic epithelial cells reveals that EMT occurs prior to tumor cell dissemination 
and that circulating mouse pancreatic tumor cells have a mesenchymal phenotype 
(Rhim et al, 2012). The phenotypic similarity between the primary mammary tumor 
and the secondary tumor metastasis further supports a role for both EMT and MET 
in the metastatic progression of cancer. 
Similar to EMT in development, reduced E-cadherin expression is a critical 
feature of EMT in breast cancer, causing loss of the epithelial phenotype and 
increased cellular motility and invasion. Conditional deletion of E-cadherin in the 
mammary glands of mice results in invasive lobular carcinomas (Derksen et al, 
2006; Moll et al, 1993). These tumors are highly invasive while demonstrating partial 
EMT properties, indicative of an aggressive metastable EMT phenotype similar to 
that described for TSKI4 epithelial stem cells in EMT. Based upon live-cell 
microscopy experiments, it is hypothesized that collective cell migration is the 
predominant mode of tissue invasion in epithelial cancers (Friedl & Wolf, 2003; 
Brabletz et al, 2005). Furthermore, receptor tyrosine kinases including the TGFβ-
receptor, hepatocyte growth factor receptor (HGFR) and platelet-derived growth 
factor receptor (PDGFR) induce EMT in breast cancer with TGFβ being the 
dominant signaling pathway for activation of EMT (Valcourt et al, 2005; Zavadil et al, 
2001; Jechlinger, 2006; Huber, 2004; Dong et al, 2007). In H-Ras transformed 
mammary epithelial cells, TGFβ promotes a mesenchymal cellular morphology and 
the expression of EMT-inducing transcription factors SNAI1, SNAI2 and TWIST1, 
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while PDGFR signaling is stimulated by TGFβ to promote a TGFβ-PDGFR autocrine 
signaling loop.  
 
Transcriptional Regulation of EMT 
 Expression of the adhesive glycoprotein and master-regulator of the epithelial 
phenotype, E-cadherin, is transcriptionally repressed by several transcription factors 
of the Snail and Zeb superfamilies (Nieto, 2002). In multiple EMT systems, SNAI1, 
SNAI2, ZEB1 and ZEB2 are coordinately upregulated during the initiation and 
progression of EMT. SNAI1 and SNAI2 are well-characterized transcriptional 
repressors of E-cadherin and function by binding the canonical E-box consensus 
sequence within the E-cadherin gene promoter. Ectopic expression of SNAI1 can 
induce EMT in several epithelial cell models, including human mammary epithelial 
cells (Mani et al, 2008).  
Transcriptional Regulation of EMT in Trophoblasts 
As TS cells are differentiated, in vitro, via the withdrawal of FGF4, SNAI1 
expression gradually increases. The expression of SNAI1 has also been 
demonstrated in the invading extravillous trophoblasts in human placenta 
development, signifying the importance of SNAI1 to the induction of trophoblast EMT 
(Zhou et al, 1997b; Perry et al, 2009). TSKI4 cells with properties of stemness and 
EMT express elevated levels of the EMT-inducing transcription factors SNAI2 and 
TWIST1, but not SNAI1 (Abell et al, 2009). This expression pattern contrasts with 
EMT induced by differentiation where SNAI1 is induced, but not SNAI2 or TWIST1, 
suggesting that different sets of transcription factors may be used to induce EMT in 
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the context of stemness. These findings suggest that maintenance of stemness is 
important for regulating the trophoblast invasive potential during the induction of 
EMT. 
Transcriptional Regulation of EMT in Breast Cancer 
 In patients with breast carcinoma, the EMT-inducing transcriptional factors 
SNAI1, SNAI2 and TWIST1 correlate with disease relapse and poor patient survival. 
The transcription factors SNAI1, SNAI2, ZEB1, ZEB2, KLF8 and E47 directly repress 
E-cadherin expression, resulting in the induction of EMT (Hajra et al, 2002; Peinado 
et al, 2007; Vandewalle, 2005; Vandewalle et al, 2008; Moody et al, 2005). 
Furthermore, expression of SNAI1, TWIST1 and ZEB1 induces EMT in human 
mammary epithelial cells (Mani et al, 2008). In addition to these direct transcriptional 
repressors, TWIST1, GSC (Goosecoid) and FOXC2 promote EMT by repressing E-
cadherin through indirect mechanisms. TWIST1 expression is upregulated in 
metastatic breast cancer and facilitates the formation of invadopodia to promote 
cancer cell invasion (Yang et al, 2004; Eckert et al, 2011). GSC is overexpressed in 
the majority of human breast tumors, and its expression in human mammary 
epithelial cells enhances cell motility, a functional indicator of EMT (Hartwell et al, 
2006). FOXC2 expression is associated with the Basal-like subtype of invasive 
ductal breast cancers, and expression of FOXC2 in MDCK cells induces the 
expression of mesenchymal markers and the serine proteases MMP2 and MMP9 
with concomitant increases in cellular invasion (Mani et al, 2007). Collectively, 
multiple EMT-inducing transcription factors result in decreased E-cadherin 
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expression, suggesting the importance of precise control of this gene for the 
progression of the EMT-traits associated with breast cancer. 
 
Epigenetic Regulation of EMT 
 Recent studies have demonstrated an increasingly significant role for 
epigenetic mechanisms in the regulation of critical developmental programs 
important to the maintenance of cellular plasticity and to the establishment of cell 
fate commitment (Bernstein et al, 2006; Ng et al, 2008). EMT is a cellular 
reprogramming event that is reactivated during the metastatic progression of cancer, 
suggesting epigenetic control of the EMT program. The main mechanisms of 
epigenetic regulation include DNA methylation, histone methylation, histone 
acetylation and non-coding RNAs (Kouzarides, 2007; Jenuwein, 2001). These 
epigenetic mechanisms regulate how chromatin is organized and how genes are 
expressed without directly altering the DNA sequence.  
Epigenetic Regulation of EMT in Trophoblasts 
The first cell fate decision during development generates two primary 
lineages of the blastocyst, the trophoectoderm that differentiates into the trophoblast 
subtypes of the placenta and the inner cell mass that forms the embryo (Sutherland, 
2003). In contrast to pluripotent embryonic stem cells responsible for the formation 
of the embryo, DNA of the trophoblast epigenome is hypomethylated. This 
hypomethylation is critical for implantation and trophoblast differentiation. As 
trophoblasts differentiate into a more invasive subtype, occurring simultaneously 
with the progression of EMT, the trophoblast epigenome is continually demethylated. 
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Reduced DNA methylation promotes activation of genetic information critical to 
trophoblast lineage commitment (Hemberger, 2007; 2010; Rossant et al, 1986; Ng et 
al, 2008; Santos et al, 2002). Despite global hypomethylation of the trophoblast 
lineage, DNA methylation is indispensable for extraembryonic development. For 
example, the DNA methyltransferase regulatory factor DNMT3L is highly expressed 
in the epithelial trophoectoderm, and DNMT3L-deficient mice exhibit multiple 
trophoblast defects, including failure to form syncytiotrophoblasts of the placenta 
(Arima et al, 2006; Bourc'his, 2001; Hata et al, 2002). Furthermore, recent genome-
wide sequencing studies have demonstrated that DNA hypomethylation is located 
primarily in the intergenic regions, which raises the question of the importance of 
intergenic DNA methylation for the control of genetic information.  
Histone modifications comprise the second layer of trophoblast epigenetic 
regulation. Gene expression levels are controlled by the degree of chromatin 
compaction, which is mediated by wrapping DNA around an octamer of four core 
histones H2A, H2B, H3 and H4. The charged tails of histones are often modified by 
acetylation and methylation marks, which generally contribute to the respective 
activation or repression of genetic information. The repressive histone modification 
H3K27 tri-methylation (H3K27me3) conferred by the multi-subunit Polycomb 
complex has been extensively studied for control of gene expression during 
differentiation of embryonic lineages. Immunohistochemistry of the mouse blastocyst 
reveals reduced levels of H3K27me3 in the trophectoderm compared to the inner 
cell mass (Hemberger, 2007; O'Carroll et al, 2001; Pasini et al, 2004; Wang et al, 
2002). Furthermore, genome-wide sequencing studies demonstrate that few 
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promoters in TS cells are marked by this modification (Rugg-Gunn et al, 2010). 
These findings contrast with post-implantation stage extraembryonic tissues, where 
high gene-specific levels of H3K27me3 are detected. These results suggest that an 
alternative repressive modification is dominant in TS cells and that the repressive 
H3K27me3 modification becomes important only after implantation, likely driving 
later lineage commitment decisions critical to the formation of the placenta. This 
could explain why mutants of the Polycomb complex, such as EZH2, SUZ12 and 
EED, demonstrate defects later during the development of extraembryonic tissues 
while not directly affecting TS cells (O'Carroll et al, 2001; Pasini et al, 2004). 
Specifically, EED mutants exhibit trophoblast differentiation defects demonstrated by 
failure to produce secondary invasive trophoblast giant cells, suggesting that 
H3K27me3 modifications might be important during activation of a specific 
transcriptional program (Mager et al, 2003; Kalantry et al, 2006). For example, 
invading trophoblast giant cells play important roles during the EMT events of 
placentation. Furthermore, the activating H3K4me3, the repressive H3K9me3 and 
the activating histone acetylation modifications demonstrate importance in TS cell 
maintenance, but the biological connections to EMT are unclear (Hemberger, 2007). 
Further studies with these histone modifications could provide insight into the 
importance of these marks in specific EMT programs. In chapter three, I examine the 
role of histone acetylation on maintenance of the epithelial phenotype of TS cells. 
Epigenetic Regulation of EMT in Breast Cancer 
Increasingly, epigenetic changes have been linked to the metastatic process. 
These epigenetic changes are often directed to a common gene target and provide a 
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selective advantage to multiple metastatic cancer cell types. Most attempts to 
identify the epigenetic contributions to metastasis have focused on the repressive 
modification DNA methylation. In primary breast tumors, hypermethylation of the 
CDH1 (E-cadherin) promoter was associated with lymph node metastasis, and 
CDH1 hypermethylation also correlated with TNBC (Bissell & Radisky, 2001; Perl et 
al, 1998; Caldeira et al, 2006). Furthermore, promoter hypermethylation has also 
been described for important tumor suppressor genes, while hypomethylation was 
observed in essential molecular pathways driving metastatic breast cancer, including 
the invasive pathways involving the proteases uPA, MMP2 and MMP9 (Rodríguez-
Paredes & Esteller, 2011; Esteller, 2008; Tomaskovic-Crook et al, 2009). 
In addition to DNA methylation, microRNAs (miRNAs) contribute to EMT and 
the subsequent progression of breast cancer. miRNAs are small non-coding RNAs 
that control gene expression through inhibition of translation or RNA decay. A variety 
of miRNAs demonstrate specificity for molecules important for cell-cell junction 
integrity, cell-cell adhesion, cellular migration and angiogenesis (Garzon et al, 2009). 
Notable EMT-regulatory miRNAs include the miR200 family, miR205 and miR34. 
These miRNAs, which repress ZEB1/2, TGFβ2, β-catenin, BMI1 and SNAI1, are 
upregulated in invasive ductal and metaplastic breast cancers (Gregory et al, 2008). 
Each of the aforementioned miRNA-regulated genes encodes critical EMT-inducing 
molecules. Additionally, Rho/Rac signaling molecules are inhibited by a second set 
of miRNAs, miR10b, miR21 and Let7i, thereby affecting EMT-specific functions, 
such as cancer cell motility and invasion. Lastly, miR9 and miR155 regulate cell-cell 
junction integrity, adhesion and angiogenesis through direct inhibition of E-cadherin 
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and RhoA (Garzon et al, 2009; Johnson et al, 2005; Yanaihara et al, 2006; Volinia et 
al, 2006; Chan, 2005). Collectively, the miRNAs have emerged as important 
regulatory mechanisms controlling feedback loops in the metastatic progression of 
breast cancer.  
 
Connections between EMT and Stemness Properties 
  Several studies have reported the relationship between EMT and stemness 
properties. The transcription factor SNAI1 is well characterized for its ability to 
induce EMT in multiple epithelial cell systems. Interestingly in human mammary 
epithelial cells, overexpression of SNAI1 or TWIST1 not only induces EMT, but also 
results in the acquisition of stem cell properties (Mani et al, 2008; Morel et al, 2008; 
Floor et al, 2011). Furthermore, TWIST1 promotes EMT while bypassing cellular 
senescence, connecting EMT to an unrestricted proliferative capacity (Ansieau et al, 
2008). More recently, mesenchymal-epithelial transition (MET), the reverse process 
of EMT, was shown to occur in parallel with the reprogramming of fibroblasts to 
induced pluripotent stem cells (iPS) (Li et al, 2010). Similarly, in TS cells, the 
coexistence of EMT and stemness properties is demonstrated by TSKI4 cells. TSKI4 
cells have robust stem cell features similar to those of TSWT cells, including 
equivalent levels of expression of the trophoblast stem cell marker CDX2 (Abell et al, 
2009). Thus, TSKI4 cells, characterized as self-renewing, multipotent stem cells in a 
highly invasive intermediate, metastable EMT state, highlight the association 
between stemness properties and EMT. Obviously, such a phenotype has the 
potential to cause severe disease pathologies. During the pathophysiological 
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progression of placenta accreta, trophoblasts at the maternal-placental interface with 
increased invasive capacity resemble self-renewing and highly proliferative TS cells 
in the early stages of implantation and placenta development. Although the genetic 
basis for accreta is unknown, the phenotype highlights the ability of stem cells to 
display EMT properties (Perry et al, 2009). In addition to TSKI4 cells, EMT 
metastability has been reported in colorectal cancer cells and progenitor cells of 
various organs undergoing EMT. During colorectal tumor remodeling and 
metastasis, immunohistochemistry of colon adenocarcinomas demonstrated the 
simultaneous retention of branched epithelial structures stabilized by E-cadherin and 
invading mesenchymal protrusions marked by high levels of β-catenin, SNAI1 and 
fibronectin expression (Brabletz et al, 2001). Furthermore, the Claudin-low subtype 
of breast cancer, which is characterized by its EMT features, also exhibits stem-like 
properties, as demonstrated by overlapping gene expression profiles with breast 
cancer stem cells identified by the CD44+/CD24-/low antigenic phenotype and bipotent 
progenitor cells identified by the EpCAM(-)/CD49f+ profile (Al-Hajj et al, 2003; 
Hennessy et al, 2009; Prat et al, 2010; Sheridan et al, 2006; Reya et al, 2001). 
Collectively, these studies reveal a connection between the cellular plasticity 
associated with the induction of EMT and the maintenance of stem-like 
characteristics. In the context of EMT and stemness, the importance of identifying 
TSKI4 cells is that they were the first example of a point mutation targeting the activity 
of a kinase (MAP3K4) that causes loss of epithelial cell maintenance, while allowing 
a self-renewing, multipotent stem cell to be in a permanent metastable EMT. The 
TSKI4 cell phenotype clearly shows that dysregulation of kinase signaling networks 
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can induce a metastable EMT with properties arguably similar to those proposed for 
the controversial tumor initiating or cancer stem cell. These results suggest that 
characterization of these signaling networks might provide new therapeutic 
strategies to reverse these EMT-associated pathologies.  
 
Conclusions and Outlook 
Unlike cancer metastasis, trophoblast invasive potential is temporally and 
spatially restricted during normal development. We propose that studies aimed at 
understanding the regulatory mechanisms restricting EMT and invasiveness of 
primary epithelial stem cells can also provide insight into signaling networks 
responsible for management of metastatic cancer. Due to the intersecting features of 
developmental and malignant EMT subtypes, a complete picture of this complex 
cellular program, which is fundamental to development and reactivated in adult 
tissues during disease progression, can and should be studied from multiple 
biological perspectives. Significant therapeutic interest in the reversal of EMT is 
highlighted by the exploration of synthetic molecular compounds to restore E-
cadherin expression (Stoops et al, 2011). Furthermore, the controlled induction of 
MET could have benefit for the reversal of several pathophysiological states where 
there is a dysregulated EMT. A greater understanding of the genes important for 
EMT may elucidate new signaling pathways to target for treatment of metastatic 
Claudin-low and Basal-like breast cancer, which are refractory to most current 
treatments. 
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Objectives for this Project 
Define the Epigenetic Regulatory Mechanisms of EMT in Epithelial Stem Cells 
Using several epithelial trophoblast stem (TS) cells model systems, we 
examined the molecular and epigenetic mechanisms important for the first 
developmental EMT events of implantation and placenta formation. One of these TS 
cell models was isolated from conceptuses with a point mutation in MAP3K4, a 
kinase regulating JNK and p38 MAPK pathways, that renders the kinase inactive 
(TSKI4 cells) and results in cells in an intermediate metastable state with both EMT 
and stemness properties. Due to the overlapping phenotypes between KI4 mice and 
mice deficient for the histone acetyltransferase CBP, it was hypothesized that 
trophoblast EMT programs are regulated by epigenetic mechanisms of histone 
acetylation. Histone acetylation is associated with active gene transcription due to its 
ability to decondense and open chromatin. KI4 and CBP knock-out mice display 
skeletal, neural tube and craniofacial defects combined with growth retardation and 
embryonic lethality. Studies with TSKI4 cells, in addition to two separate models of TS 
cell EMT (TSSNAI1 and TSshCBP cells), allowed the discovery of an epigenetic 
mechanism reliant on H2B acetylation important for the maintenance of the epithelial 
phenotype of TS cells. Due to incomplete modulation of the epigenetic landscape, 
these TS cell models are uniquely paused in an intermediate EMT state and provide 
tractable systems to examine the molecular and epigenetic mechanisms contributing 
to the transient, intermediate EMT states. Furthermore, an intersecting EMT gene 
signature was found in mesenchymal Claudin-low breast cancer cells characterized 
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by EMT and stemness properties, highlighting the importance of studying EMT from 
multiple biological perspectives.  
Define Novel Genes Important for the Induction of EMT in Triple Negative 
Breast Cancer 
In order to understand the similar connections between developmental and 
breast cancer EMT, we identified an intersecting EMT gene signature from analysis 
of microarray gene expression data shared by TSKI4 cells developmentally entering 
EMT and the Claudin-low subtype of TNBC. Similar to human Claudin-low breast 
cancer cell lines and tumors, TSKI4 cells exhibit an increase in the mesenchymal 
markers VIM, CDH2, SNAI2 and TWIST1 with loss of the epithelial differentiation 
and cell adhesion markers CD24, KRT7/8/19 and CLDN4. With a few notable 
exceptions such as SNAI2, TWIST1, VIM and CDH2 (N-cadherin), many of the 
genes in this EMT signature are uncharacterized with respect to EMT. It was 
hypothesized that the upregulated genes within this EMT gene signature define a 
novel set of genes with importance in EMT and maintenance of the mesenchymal 
phenotype. Using a phenotypic RNAi screening approach, we identified ten genes 
important for establishing the Claudin-low mesenchymal phenotype of an EpCAM(-) 
population of SUM149 and SUM229 Basal-like breast cancer cells. Of particular 
importance, the SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c was 
identified and characterized for its ability to induce EMT in a Wnt5a-dependent 
manner in human mammary epithelial cells, highlighting a new mechanism of 
epigenetic regulation of EMT. 
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Figure 1.1: Comparison of EMT Subtypes in Development and Cancer 
Metastasis  
The first developmental EMT that occurs during implantation of the blastocyst into 
the uterine epithelium (left panel) and EMT associated with the metastatic 
progression of cancer (right panel) are shown. MET indicates mesenchymal-
epithelial transition.
 
Chapter II 
Materials and Methods 
 
Chapter 3 Methods 
Cell Lines, Culture Conditions and Transfections 
TSWT and TSKI4 cells of normal karyotype were isolated from heterozygote crosses of 
mice with a targeted mutation of MAP3K4 (K1361R) as previously described (Abell 
et al, 2009). TS cells were cultured without feeders in 30% TS media (RPMI 1640, 
20% fetal bovine serum, 1% penicillin and streptomycin (PS), 1% L-glutamine, 1% 
sodium pyruvate and 100 µM β-mercaptoethanol) and 70% MEF conditioned TS cell 
media, supplemented with FGF4 (37.5 ng/ml) and Heparin (1 mg/ml). For 
differentiation, TS cells were cultured in TS media only.  293T cells were cultured in 
Dulbecco’s modified Eagle’s high glucose medium with 10% FBS and 1% PS. 
Transfection of 293T cells was performed in 10 cm dishes for 24 hours with 
LipofectaminePlus (Invitrogen) according to manufacturer’s specifications. The Snail 
expression plasmid was a kind gift from Dr. Paul Wade. Snail was subcloned 
between EcoRI and XhoI restriction sites of pcDNA3.1(+). G418 was used to stably 
select for TS cells overexpressing Snail. Published plasmids include HA-MAP3K4, 
HA-MAP3K4 kinase inactive, HA-JNK, FLAG-p38, HA-CBP, HAT-inactive HA-CBP, 
Myc-p300 and HAT-inactive Myc-p300 (Gerwins, 1997; Abell, 2004; Bradney, 2003). 
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Lentivirus Production, Infections of TS cells and shRNA Knockdown of CBP 
and p300 
To produce replication incompetent lentivirus, 293T cells were co-transfected with 
either GFP or shRNA constructs in pLKO.1 (Open Biosystems) in combination with 
pMD2.G and psPAX2 (Addgene) using Lipofectomine Plus reagent (Invitrogen). 24 
hours later, cell media was changed. Viral supernatants were harvested at 48 and 
72 hours post-transfection by ultracentrifugation. Viral pellets were resuspended in 
100 µl of 30% TS media (RPMI 1640, 20% fetal bovine serum, 1% PS, 1% L-
glutamine, 1% sodium pyruvate and 100 µM β-mercaptoethanol) and 70% MEF 
conditioned TS cell media, supplemented with FGF4 (37.5 ng/ml) and Heparin (1 
mg/ml) and stored at -80° C. Infection of TS cells was performed essentially as 
previously described (Odiatis & Georgiades, 2010). Briefly, TSWT cells were plated 
overnight at 1 X 104 cells per 24 mm well in a Nunc 4-well dish, and then infected 
with 100 µl of lentivirus and polybrene (5 µg/ml). The next day, cells were washed 
five times in PBS and TS media was replaced. Three days after infection, cells were 
examined for GFP positive cells as a indicator of transduction efficiency, showing a 
40-50% infection efficiency. Puromycin (2 µg/ml) was used to select for transduced 
cells. Selection was complete after seven days of puromycin treatment. Knockdown 
of CBP or p300 was measured by qRT-PCR as described in Real-time Quantitative 
RT-PCR. 
Invasion Assays and Isolation of Invasive Trophoblasts (TINV) 
Invasion assays were performed essentially as previously described (Abell et al, 
2009). Briefly, cells were plated on growth factor-reduced Matrigel (BD Biosciences) 
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coated 8 µM pore transwell chambers. After 48 hours, invasion assays were 
terminated. Non-invading cells were removed from the top of the transwells by 
washing and swabbing. Invaded cells (TINV) were isolated from the bottom of the 
transwell chambers by either direct lysis in RNAeasy buffer for RNA isolation or by 
trypsinization for immunofluorescence, ChIP, and Western blotting. For quantitation 
of invasion, chambers were fixed in 3% paraformaldehyde for ten minutes and 
stained with DAPI nuclear stain. For each transwell, five 10X fields were imaged and 
counted. 
Real-Time Quantitative RT-PCR (qRT-PCR) 
Total RNA was isolated using RNeasy Plus minikit (Qiagen).  cDNA was synthesized 
from 3 µg RNA using High-Capacity reverse transcription kit (Applied Biosystems). 
Applied Biosystems 7500 RT-PCR system with inventoried TaqMan probes was 
used to quantify gene expression levels normalized to β-actin expression. PCR for 
TS cell marker Cdx2 was carried out at 61oC for 35 cycles to generate a 284 bp 
product. The following primers were used for semi-quantitative RT-PCR: sense 5’-
CATCCCCGCCTCTACAGCTTA-3’ and 5’-ATACATGCTCACGTCCTTGTCC-3’. 
ChIP assays were quantified by real-time PCR using Absolute Blue SYBR green 
PCR mix (Thermoscientific) and the Applied Biosystems Fast 7500 Real-Time PCR 
System. Fold enrichment was determined by the 2-ΔCT method. PCR primers were 
designed to amplify approximately 75-100 bp fragments from genomic DNA using 
Primer Express 3.0 (Applied Biosystems). Primers used for ChIP-qRT-PCR are 
described in Table 2.1. 
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Agilent Gene Expression Arrays 
For gene arrays, cDNA was competitively hybridized to a 4 x 24,000 Agilent gene 
array. Raw gene expression data was analyzed using Agilent GeneSpringGX 
software to produce a ranked gene list based upon the log2 ratio of Agilent probe 
intensity appearing in at least three gene arrays with a Benjamini-Hochberg p-value 
< 0.05. Heat maps were prepared by hierarchical clustering in Cluster 3.0 and 
JavaTreeView. Published breast cancer cell line data from Neve et al. was clustered 
according to the methods described above (Neve et al, 2006). 
Comparative Expression and GO Pathway Analysis 
Comparative gene expression analysis was used to determine the TINV gene 
signature by filtering for genes enriched in the TINV versus TDIFF statistically analyzed 
gene sets (Benjamini-Hochberg p-value < 0.05 and a log2 ratio > +/- 1). Enrichment 
was quantified by the absolute value of the log2 ratios between TINV and TDIFF gene 
sets using a secondary cutoff log2 ratio > 0.5. The TINV gene signature was assessed 
for overlap with the TSKI4 statistically analyzed gene set to produce the minimal 
trophoblast EMT signature. The NIH DAVID gene ontology bioinformatics database 
was used to cluster genes into canonical KEGG signaling pathways from both the 
ChIP-seq and Agilent array datasets of statistically significant genes with a p-value < 
0.05 and a log2 ratio < -1. 
Microarray Analyses of Human Breast Tumors and Cell Lines 
Two publicly available gene expression microarray datasets (UNC337 [GSE18229] 
for tumors and Neve et al. for cell lines) were analyzed as previously described 
(Neve et al, 2006; Prat et al, 2010). For human tumors, we obtained the Claudin-low 
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human tumor expression signature of up- and down-regulated genes from 
Supplemental Data.xls in Prat et al. (http://breast-cancer-
research.com/content/supplementary/bcr2635-s2.xls). For human cell lines, we 
performed a Significance Analysis of Microarrays (SAM) by comparing the 
previously described CL cell lines versus the rest (false discovery rate <5%). The 
resulting up- and down-regulated gene sets defined the CL cell line signature 
analyzed. Finally, overlap between two signatures was estimated using the exact 
hypergeometric probability implemented in R package (http://cran.r-project.org). In 
each overlap analysis, only genes present in both platforms were considered. The 
accession number for the microarray data is GSE27883. 
Generation and Analysis of Chimeras 
GFP expressing TSWT and TSKI4 cells generated as described above in Lentivirus 
Production and Infections of TS Cells were used to generate chimeric embryos. 
The Animal Models Core at the University of North Carolina at Chapel Hill performed 
blastocyst injections using standard procedures. Conceptuses were dissected at 
E6.5 and E9.5, where date of blastocyst injection was considered E3.5. Samples 
were fixed for one hour in PBS containing 4% paraformaldehyde and 1% sucrose, 
washed, and put through a sucrose gradient. After embedding and freezing in OCT, 
samples were cryosectioned at 18 µm sections. All animal and embryo work was 
performed according to both university and federal guidelines for the use of animals. 
Immunofluorescence 
Immunostaining was performed as previously described (Abell et al, 2009). Briefly, 
TS cells cultured on glass coverslips for two days were fixed in 3% 
	  29 
paraformaldehyde, 1% sucrose, 1% PBS for 10 min. Coverslips were washed with 
PBS, permeabilized for 5 min with 0.2% Triton and blocked for one hour with 10% 
goat serum. Coverslips were incubated for one hour at room temperature with anti-
E-cadherin antibody (1:1000), washed for 30 min and then incubated at room 
temperature for one hour with Alexa 555 anti-mouse secondary antibody (Invitrogen) 
and DAPI nuclear stain. 
Western Blotting of Whole-cell, Nuclear and Histone Lysates  
Whole cell and nuclear lysates were isolated as previously described (Abell et al, 
2009). For histone lysates, cells were lysed on ice in buffer containing PBS, 1% 
Triton-X and 1 mM PMSF. Pellets were spun at 2000 rpm for 10 min at 4o C and 
extracted overnight in 0.2 N HCl with shaking at 4o C. Western blots were performed 
with the antibodies specified in Table 2.2. 
In vitro Histone Acetyltransferase (HAT), Immunoprecipitation, and Kinase 
Assays 
HAT assays were performed using Millipore (cat. # 17-289) HAT assay kit. Briefly, 
HA-CBP and/or Myc-p300 were immunoprecipitated in PBS with 5 µg anti-HA or 
anti-myc antibodies specified below in Table 2.2. Following immunoprecipitation, 
CBP/p300-bound protein G sepharose beads were incubated for 30 min at 30° C in 
a reaction mixture containing 100 µM acetyl-CoA, 1.4 µCi [3H]-acetyl-CoA (specific 
activity 200 mCi/mmol), 10 µg purified core histones and HAT buffer provided by the 
manufacturer (Millipore). The reaction mixture was spotted onto P18 filter paper, 
washed with sodium phosphate buffer (pH 9) and quantitated with a Beckman liquid 
scintillation counter. Total HAT activity was measured from nuclear lysates 
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according to the same method. Kinase assays were performed as previously 
described (Abell et al., 2007). Briefly, HA-CBP or Myc-p300 immunoprecipitates 
were incubated for 20 min at 30° C with HA-MAP3K4 and HA-JNK or FLAG-p38 in 
kinase buffer containing 0.5 mM ATP and 10 µCi γ- 32P[ATP]. Proteins were 
separated by SDS-PAGE and quantitated by autoradiography using a 
Phosphorimager. 
Chromatin Immunoprecipitation Coupled to High Throughput Sequencing 
(ChIP-seq) 
Cells were fixed for 10 min in 1% formaldehyde, sonicated (VCX130 Ultrasonicator) 
and immunoprecipitated with 5 µg anti-H2BK5Ac and Protein A dynabeads 
(Invitrogen) (Wang et al, 2008). Crosslinking was reversed by overnight incubation at 
65oC. DNA was purified with the MinElute PCR purification kit (Qiagen). Library 
preparation for Illumina ChIP-seq was performed according to manufacturer’s 
instructions (Illumina). Illumina Solexa GA II was used to produce ~36 bp sequence 
reads, which were mapped to the mouse genome using Mapping and Alignment with 
Quality (MAQ) software in conjunction with EpiCenter for comparative analysis as 
described under Epicenter ChIP-seq Analysis Tools. PCR conditions and primers 
used for ChIP-seq validation are described in Table 2.2.   
Epicenter ChIP-seq Analysis Tools 
For both ChIP-seq and mRNA-seq data analysis, we used MAQ (Li et al., 2008) to 
map read tags to the mouse reference genome (NCBI build 37.1/mm9), and used 
EpiCenter to identify significant changes between TSWT and TSKI4 cells (Huang et al, 
2011). EpiCenter is a versatile tool for comparative analysis of both ChIP-seq and 
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mRNA-seq data to identify differential changes. EpiCenter is freely available at 
http://www.niehs.nih.gov/research/resources/software/epicenter.      
Read mapping and quality filtering: For the analysis of H2BK5Ac ChIP-seq data, 
read tags were mapped directly to the mouse reference genome. Reads with MAQ 
alignment quality scores <10 (i.e. number of mismatches > 2) were filtered out to 
remove poorly aligned reads or non-uniquely mapped reads. After the quality filter, 
about 38.7 (87.8%) and 24.1 (88.9%) million reads were uniquely mapped to the 
mouse reference genome in TSWT and TSKI4 cells, respectively. For the analysis of 
gene expression mRNA-seq data, read tags were directly mapped to cDNA 
sequences of all mouse RefSeq genes. After filtering out reads with alignment 
quality scores <10, about 41.6 and 33.6 million reads were uniquely mapped to the 
RefSeq cDNA sequences. We also mapped the reads to the mouse reference 
genome, but we had about 20% fewer mapable reads because reads from exon 
junctions could not be mapped back to the reference genome.  The results reported 
here were based on cDNA sequence mapping data.  
Data normalization: Since H2BK5Ac ChIP-seq data showed broad change 
between TSWT and TSKI4 samples, we chose the ratio of the numbers of mapped 
reads to adjust the difference of read coverage depths. We also used EpiCenter’s 
linear least squares regression method to estimate the read coverage ratio for 
normalization. The 300 most significant genes were very similar between the two 
approaches, although fewer genes were identified with the regression-based 
approach. For mRNA-seq data analysis, we used EpiCenter's "parsimony" 
normalization procedure to adjust read coverage difference. The “parsimony” 
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automatically adjusted normalization ratio to minimize the number of significant 
genes by the EpiCenter’s exact rate ratio test.   
Statistical tests of significance: EpiCenter first tested whether the read tag count 
in each region or gene was significantly larger than that expected under cell-type 
specific background noise. Regions/genes whose read-tag counts did not 
significantly exceed the background noise in both TSWT and TSKI4 samples were 
filtered out. For those regions/genes retained, we then used EpiCenter exact rate 
ratio test to find whether the difference in read counts was significantly larger than 
that expected from Poisson variation. In mRNA-seq data analysis, we also used 
EpiCenter’s Z-test to determine if the difference in read counts exceeded normal 
variation. We used Benjamini-Hochberg correction to adjust p-value for multiple 
testing in analysis of both ChIP-seq and mRNA-seq data. The technical details of 
EpiCenter were published in Huang et al. (Huang et al, 2011).  
 
Chapter 4 Methods 
 
Cell lines, Culture Conditions, Constructs and Transfections 
The primary human mammary epithelial cell line (HMEC), immortalized using the 
retrovirus pBabe-hygro-hTERT, was cultured as previously described (Troester, 
2004). Basal-like breast cancer lines SUM149 and SUM229 cells were cultured in 
HuMEC medium, 5% FBS, 1% penicillin and streptomycin (PS) plus bovine pituitary 
extract and HuMEC supplement or Ham’s F12 medium, 5% FBS, 1% PS plus 5 
µg/mL insulin and 1 µg/mL hydrocortisone, respectively. 293T cells were cultured in 
Dulbecco’s modified Eagle’s high glucose medium with 10% FBS and 1% PS. 
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Transfection of 293T cells was performed in 15 cm dishes for 24 hours with 
Lipofectamine Plus (Invitrogen) according to manufacturer’s specifications. The 
Smarcd3/Snail/Slug Gateway entry plasmid was subcloned into a lentiviral FLAG-
Gateway destination vector. The lentiviral FLAG-Gateway destination vector was a 
kind gift from Dr. Ben Major. The EpCAM reporter was subcloned between 
XbaI(2708) and NotI(4101) restriction sites and replaced the CMV-IE-Promoter-
Enhancer/Turbo-GFP tag in the pGIPZ empty vector. The EpCAM promoter 
expression plasmid was a kind gift from Dr. Marianne Rots.  
Lentivirus Production and Infections of HMEC Cells  
To produce replication incompetent lentivirus, 293T cells were co-transfected with 
either pGIPZ empty vector, FLAG-Smarcd3/Snail/Slug lentiviral Gateway constructs 
or the lentiviral EpCAM reporter construct in combination with pMD2.G and psPAX2 
(Addgene) using Lipofectomine Plus reagent (Invitrogen). 24 hours later, cell media 
was changed. Viral supernatants were harvested at 48 hours post-transfection by 
ultracentrifugation, and viral pellets were resuspended in 300 µL base media. 
HMECs were infected overnight with 100 µL lentivirus in 6 µg/mL polybrene. 
Puromycin (3 µg/mL) was used to select transduced cells. Selection was completed 
7 days after infection. Expression of Smarcd3/Snail/Slug was measured by qRT-
PCR. 
Fluorescently Activated Cell Sorting (FACS) 
Cells were trypsinized and filtered into single cell suspensions, resuspended in 
Hank’s balanced salt solution containing 2% FBS (HF media), and incubated with 
antibodies for 30 min at 4oC. Cells were stained with the following antibodies 
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EpCAM-FITC (Stem Cell Technologies 10109), EpCAM-APC (BD 347200), Cd49f-
PE-Cy5 (BD 551129), Cd44-APC (BD 559942) or Cd24-FITC (BD 555427). 
Unbound antibodies were washed from cells using HF media. For analytical flow, 
cells were fixed with 3% paraformaldehyde and analyzed using Beckman-Coulter 
Cyan Instrument. For sterile live-cell flow cytometry, cells were sorted using a Sony 
iCyt/Reflection Instrument. 
RNAi Screening Conditions, Immunofluorescence and High Content Imaging 
For the RNAi screen, EpCAM(-) SUM149 and SUM229 cells were reverse 
transfected in fibronectin-coated 96-well plates (Greiner) with 25 nM siRNA smart 
pools (Dharmacon) containing the combination of 4 different siRNA oligonucleotides 
for each target or control gene (siUBB for siRNA knockdown efficiency; siGAPDH for 
a negative control; siSnail/Slug for a positive control). Target genes were plated in 
duplicate on triplicate plates, and control genes were plated 2X for UBB, 6X for 
GAPDH and 8X for siSnail/Slug on triplicate plates. After 6-days in culture, cells 
were fixed with 3% paraformaldehyde, permeabilized with 0.1% Triton X and stained 
with nuclear DAPI stain, EpCAM (Stem Cell Technologes 01420) and E-cadherin 
(Cell Signaling 3195S) antibodies. EpCAM (conjugated to secondary Alexa 555) and 
E-cadherin (conjugated to secondary Alexa 488) fluorescence was measured using 
the high-content BD Pathway 855 microscope system. Changes in EpCAM and E-
cadherin expression were quantitatively measured on a single-cell basis as a 
function of the percent change in the cellular fluorescence using the CellProfiler 
image analysis software. Results were the compilation of two independent screens 
performed in triplicate. 
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Chromatin Immunoprecipitation Assays (ChIP) 
Cells were fixed for 10 min at 37oC in 1% formaldehyde, sonicated (VCX130 
Ultrasonicator) and immunoprecipitated with 5 µg anti-H3K4me3 (Abcam 8580), anti-
Smarcd3 or anti-FLAG (Sigma F7425) and Protein A dynabeads (Invitrogen). 
Crosslinking was reversed by overnight incubation at 65oC. DNA was purified with 
the MinElute PCR purification kit (Qiagen). ChIP assays were quantified by qRT- 
PCR using Absolute Blue SYBR green PCR mix (Thermoscientific) and the Applied 
Biosystems Fast 7500 Real-Time PCR System. Fold enrichment was determined by 
the 2-ΔCT method. PCR primers were designed to amplify approximately 75-100 bp 
fragments from genomic DNA using Primer Express 3.0 (Applied Biosystems). ChIP-
qRT-PCR primers include: Cdh1 sense 5’-ACCCCCTCTCAGTGGCGT-3’, and 5’-
GGAGCGGGCTGGAGTCTG; Cd44 sense 5’-AGTGGATGGACAGGAGGATG-3’, 
and 5’-TTATGTCCTTCTGGGCTCT; Cldn4 sense 5’-TCAGCCTTCCA 
GGTCCTCAA-3’, and 5’-CCCCATGGAGGCCATTG-3’; Wnt5a sense 5’-
CCTATTTTGCTCCCCGTT-3’, and 5’-AAGAGTCAGCCCCAAATT-3’. 
Matrigel Invasion Assays  
Cells were plated on growth factor-reduced Matrigel (BD Biosciences) coated 8 µM 
pore transwell chambers. After 24 hours, invasion assays were terminated. Non-
invading cells were removed from the top of the transwells by washing and 
swabbing. Invasive cells were quantified by fixing chambers in 3% 
paraformaldehyde for ten minutes and staining with DAPI. For each transwell, three 
10X fields were imaged and counted.  
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Western Blotting of Whole-cell and Nuclear Lysates  
Whole cell and nuclear lysates were isolated as previously described (Abell et al, 
2009). Western blots were performed with the following specified antibodies: EpCAM 
(Abcam 71916), E-cadherin (BD 610181), Fibronectin (Calbiochem CP70), N-
cadherin (Abcam 76057), Vimentin (Cell Signaling 5741S), γ-tubulin (Sigma T6557), 
FLAG (Sigma M5 F4042/F7425), Snail (Cell Signaling 3895S), Slug (Cell Signaling 
9585S), Brg1 (Santa Cruz sc-17796X), Brm (Abcam 15597), Phospho-PKCβ (Cell 
Signaling 9371S), Phospho-JNK (Cell Signaling 9251S), β-catenin (Sigma C7207) 
and Smarcd3/Baf60c. Smarcd3/Baf60c antibody was a kind gift from Dr. Lorenzo 
Puri. 
Real-time Quantitative RT-PCR (qRT-PCR) 
Total RNA was isolated using RNeasy Plus minikit (Qiagen). cDNA was synthesized 
from 3 µg RNA using High-Capacity reverse transcription kit (Applied Biosystems). 
Applied Biosystems 7500 RT-PCR system with inventoried TaqMan probes was 
used to quantify gene expression levels normalized to β-actin expression.  
Gene Expression Microarrays 
Transfected and control HMEC cell lines were profiled as described previously using 
44K human oligo microarrays (Agilent Technologies, Santa Clara, CA, USA) (Hu et 
al, 2006; Prat et al, 2010). The probes or genes for all analyses were filtered by 
requiring the lowest normalized intensity values in both sample and control to be > 
10. The normalized log2 ratios (Cy5 sample/Cy3 control) of probes mapping to the 
same gene (Entrez ID as defined by the manufacturer) were averaged to generate 
independent expression estimates. At least three biological replicates were used for 
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each transfected gene (i.e. each Cy5-sample). For Cy3-controls, we used the empty 
vector cell line, which was the same for all samples. All microarray data is available 
in the University of North Carolina (UNC) Microarray Database 
(https://genome.unc.edu/) and has been deposited in the Gene Expression Omnibus 
under the accession number GSE40145.  
Gene Signatures 
The previously published Claudin-low predictor and the Differentiation Score were 
evaluated as previously described (Prat et al, 2010). For each HMEC infected cell 
line (i.e. Smarcd3, Slug and Snail), we derived a gene signature by performing a 
one-class Significance Analysis of Microarrays (SAM) with a false discovery rate of 
0%. An enrichment score for each individual signature (up- and down-regulated 
genes combined) was evaluated in the previously published UNC337 dataset 
(GSE18229) of breast cancer samples representing all the intrinsic molecular 
subtypes. To do so, we calculated the inner product of each signature (gene ratio) 
and the gene expression value of each breast tumor sample. Subtype calls in the 
UNC337 dataset were used as provided in GEO (Prat et al, 2010). 
Statistical Analysis  
Gene overlap between two signatures was estimated using exact hypergeometric 
probabilities implemented in R package (http://cran.r-project.org). All microarray 
cluster analyses were displayed using Java Treeview version 1.1.4r2. Average-
linkage hierarchical clustering was performed using Cluster v3.0 (Eisen et al, 1998).  
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Gene 
Name	  
Forward Primer	   Reverse Primer	  
Mouse 
Acsl6 	   ACCCCCGCTGCCATTT	   GACCGGCCTCCAAGGTTT	  
Itgav 	   AAAGTCCCGCCGAGTATGC	   AGAAGTCCACGGCGAATCC	  
Lamb2 	   TTCCCTTGCTTTCCAACTTTACTC	   GCAGTCACTCCTCCACAATCTG	  
Trim54 	   TAGCCGGGATCCCAAGAAT	   TGCCTGTGCACCCTTCCT	  
Cdx2  TGGCTCCGCAGAACTTTGTC	   CCGCCACGTGGTAACCAA	  
Eomes  GCCTTCCACCTTTGATGTATCC	   AAAGCTTTGGCGCCTTCTCT	  
Aim1 	   CCAGCTTTGCACTTGTTGCA	   GCACGCTTGGCTCTCAGTTT	  
Arfgef1	   GGCAAGAAGACGAAGAAGAACA
TGTT	   ACTTCCTTGTCGGCCAGAATC	  
Galnt3	   CCTTAAGCGACTAGTAAAATTGC
ACAT	   TGACTGCACCCAGCTTCCA	  
Irx5 	   AACCAGACGGTGTTGAATCGT	   GGCTCCGCAACATTTTCG	  
Krt7 	   CCGCATGGAGGAATAAAAGG	   GAGGAGCAGCAGCGCGAACTC	  
Krt19 	   AGTCCGCGGTGGAAGTTTTA	   CCAGACAGCAGCCCATCAG	  
Rab25 	   TCTCCACCCGCACTGTAATG	   GTCCCAGATCTGTGCCTTGAC	  
Scyl3 	   AAGGCTTCGGTGCCAGAGT	   TGGAAACTGGCCTCAGTCAAG	  
Cobll1 	   TCAGACACCTGACACTGAACTTT
TT	   AAAAGGTTCCTATGTGTCAGGATGA	  
Ctnnd1 	   CGCCGCTCCTCTTCCA	   CTACGACGAGCTGGGCAATT	  
Dbndd2	   CCCTGGAGCGCCAACA	   GGCTGTAAAATGTCCTCAAAGA
ACT	  
Def6 	   GCACTTCCGGGATGACGAT	   TGAGGTAGGGCATGTAACCTTG
A	  
F11r 	   AGGACCGATTGGTTGGAAAAG	   GCACCCTGAGGAAAACTGTCA	  
Ipp 	   GACAAACATGCCCAGCTCATC	   TCACAGAAATGCTGTCCACTTCT
C	  
Isg20 	   CGCTGCAGCATTGTGAACA	   CGGGTCGGATGTACTTGTCA	  
Plxnb1 	   TGCAGAGGAAGGCCGTGTAC	   ATACTCGCCCATCCCATGAG	  
Pou3f1 	   GCCCACCGCAGGATCTC	   TTCTGGAGGTCCCTGCTGTAG	  
Wwc1 	   GACGGCAAGGTCTACTACATAGA
TCA	   CCGCGGGTCGATCCA	  
Yme1l1 	   GTGTTACCCTGCGTCAGAAATG	   CTATAACAGCATGTTCATATTCA
CAAAATC 
Human 
Aim1 	   AACGCGGCCAGCGATA	   CCGCGGAGATTTCACTTTCT	  
Arfgef1 	   GGCCGACAAGGAAGTGAAGA	   CCACCTCGCAAGCTTTGC	  
Galnt3 	   GCTTGGTGCAGTAATTTTTTTCTT
T	   TTTCCATCCTTGATTCCTCTTTG	  
Irx5 	   CCATTGCCTTGGTCAAAAATG	   GAGGCGGACGGCTGGTA	  
Krt7 	   CAGATCAAGACCCTCAACAACAA
G	   GTCCAGTCCCGCTCACCTT	  
Krt19 	   AAGCTAACCATGCAGAACCTCAA	   CAGGGCGCGCACCTT	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Rab25 	   TCTCCACCCGCACTGTGAT	   TGTCCCAGATCTGAGCCTTGA	  
Scyl3 	   ACACTGAGAGAACCACCATTTAC
CT	   TCTTGCAGTACAGCGGGATAAAC	  
Cobll1 	   CCAAAGCTCTGACCCAGAACA	   TCTCCCGAACGGATTGCA	  
Ctnnd1 	   CGACCGCCAGCATCTTG	   CCCGGGTCAGCTTCTCAAA	  
Dbndd2 	   GGCAAAAATTCTTCGAGGACAT	   GATGCAGATGGGACAGAGGAA	  
Def6 	   GCCCTGCGCAAGGAACT	   ACGTCCAGCGCGGTAAAG	  
F11r 	   CCTGGCATTGGGCAGTGT	   TTCTCAGGAATTCTGACTTCAGG
TT	  
Ipp 	   AGGCTGCTGATAGTCCTTTTTCA	   CATCTTATTGATTTGGGCCAAGA	  
Isg20 	   TCGTTGCAGCCTCGTGAA	   GGCCGGATGAACTTGTCGTA	  
Plxnb1 	   CCCCTTCCACCAACTGCAT	   TTGCCAGGTGCTGCAGATAC	  
Pou3f1	   CCGAATTTCTGACCCATCTCTATT	   ACAAACAGAAGAAGAAACGGAG
AAG	  
Wwc1 	   TCGACGGCAAGGTCTACTACATA
G	   CCGCGGGTCGATCCA	  
Yme1l1 	   CGGTGCAACCCCAGGTTA	   TGGTGTATGGAAGGCATTGATG	  
 
Table 2.1 ChIP-PCR Primers 
Table lists each primer used for ChIP-qRT-PCR to confirm the results of the 
H2BK5Ac ChIP-seq experiments that measure H2B promoter acetylation levels 
described in chapter three. 
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Antibody specificity Company Catalogue number 
vimentin (rabbit mAb) Cell Signaling 5741 
vinculin (mouse mAb) Sigma V-9131 
E-cadherin (mouse mAb) BD Transduction 610181 
actin (mouse mAb) Sigma A-3853 
fibronectin (rabbit Ab) EMD Calbiochem CP70-100UG 
N-cadherin (rabbit Ab) Abcam AB76057 
gamma tubulin Sigma T6557 
p300 (mouse mAb) Millipore 05-257 
CBP (rabbit pAb) Abcam ab2832 
H2AK5Ac (rabbit pAb) Cell Signaling 2576 
H2BK5Ac (rabbit pAb) Cell Signaling 2574 
H2BK5Ac (rabbit pAb, 
ChIP) 
Abcam ab40886 
H2BK12Ac (rabbit pAb) Epitomics 1755-1 
H2BK15Ac (rabbit pAb) Epitomics 2170-1 
H2BK20Ac (rabbit pAb) Cell Signaling 2571S 
H3K9Ac (rabbit pAb) Cell Signaling 9671 
H4K8Ac (rabbit pAb) Cell Signaling 2594 
Total H2A (rabbit pAb) Cell Signaling 2572 
Total H3 (rabbit pAb) Cell Signaling 9715 
H3K9me3 (rabbit pAb) Abcam ab8898 
H3K4me3 (rabbit pAb) Abcam ab8580 
Anti-HA (rabbit pAb) Santa Cruz 12CA5 
Anti-Myc (mouse mAb) Santa Cruz sc-40 
 
Table 2.2 Antibodies and Sources 
Table describes the type and source of each antibody used in the Western blotting, 
ChIP and immunoprecipitation experiments performed in chapter three
 
Chapter III  
 
MAP3K4/CBP Regulated H2B Acetylation Controls Epithelial-Mesenchymal 
Transition in Trophoblast Stem Cells1 
 
Introduction 
The transition of epithelial cells to motile mesenchymal cells occurs through a 
process known as epithelial-mesenchymal transition (EMT), in which epithelial cells 
lose cell-cell contacts and apical-basal polarity concomitantly with the acquisition of 
a mesenchymal morphology and invasive properties. Several molecular events are 
coordinated for the initiation and completion of EMT including loss of the adhesive 
cell-surface protein E-cadherin, activation of EMT-inducing transcription factors and 
reorganization of the actin cytoskeleton (Yang & Weinberg, 2008). During 
development, EMT is responsible for proper formation of the body plan and for 
differentiation of many tissues and organs. Examples of EMT in mammalian 
development include implantation, gastrulation and neural crest formation (Thiery et 
al, 2009). Initiation of placenta formation regulated by trophoectoderm differentiation 
is the first, and yet most poorly defined developmental EMT.   
The commitment of stem cells to specialized cell types requires extensive 
reprogramming of gene expression, in part, involving epigenetic control of 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 The data presented in this chapter was performed in collaboration with Dr. Amy 
Abell and was published as a co-first author manuscript in Cell Stem Cell (Abell et al, 
2011).	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transcription. The first cell fate decision is the formation of the trophoectoderm and 
the inner cell mass of the blastocyst. Trophoblast stem (TS) cells within the 
trophoectoderm maintain a self-renewing state in the presence of FGF4 (Tanaka, 
1998).  For TS cells and most other tissue stem cells, self-renewal is defined as cell 
division with the maintenance of multipotency . Diminished exposure to FGF4 
induces TS cells to give rise to multiple differentiated trophoblast lineages, each 
required for establishment of the placenta. For implantation to occur, TS cells must 
undergo morphological changes to a more invasive phenotype, thereby exhibiting 
the functional hallmarks of EMT.  
An emerging topic in the EMT field is the intersection between EMT and 
stemness. We have previously characterized the developmental defects of a 
genetically engineered mouse with the targeted inactivation of MAP3K4, a serine-
threonine kinase important for JNK and p38 activation in response to FGF4 (Abell et 
al, 2009). In addition to embryonic defects, the MAP3K4 kinase-inactive mouse (KI4) 
has trophoblast defects resulting in hyperinvasion, defective decidualization, fetal 
growth restriction and implantation defects (Abell et al, 2005; 2009). TS cells isolated 
from the conceptuses of KI4 mice (TSKI4 cells) exhibit the hallmarks of EMT, while 
maintaining TS cell multipotency and are a unique developmental stem cell model to 
examine parallels between EMT and stemness. 
Recently, EMT has been linked to the metastatic progression of cancer and to 
the acquisition of stem cell properties (Mani et al, 2008). The Claudin-low (CL) 
intrinsic molecular subtype of breast cancer is characterized by its mesenchymal 
and stem cell-like properties. In concordance with the stem cell-like CD44+/CD24-/low 
	  43 
and CD49f+/EpCAM- antigenic phenotypes of breast tumor initiating cells (TICs) and 
mammary stem cells, gene expression profiling demonstrated that CL tumors have 
reduced expression of several epithelial differentiation markers, while exhibiting 
increased expression of certain stemness and mesenchymal markers (Lim et al, 
2009; Prat et al, 2010).  
Herein, we define an epigenetic mechanism important for the initiation of the 
first EMT event during development. Using TSKI4 cells uniquely trapped in EMT prior 
to initiation of the trophoblast differentiation program, we capture the genetic and 
epigenetic profile of the intersection between the properties of EMT and stemness. 
Importantly, we identify a molecular mechanism reliant on the histone 
acetyltransferase CBP that is responsible for controlling epigenetic remodeling 
during EMT in TSKI4 cells. TS cells lacking CBP (TSshCBP) expression exhibit an EMT 
similar to TSKI4 cells, which is mediated by the selective loss of H2A and H2B 
acetylation. Comparison across developmental and cancer EMT models exhibiting 
stem-like properties demonstrated a highly significant intersection between the gene 
expression profiles of TSKI4 cells and CL human tumors and cell lines. Repressed 
genes from the EMT gene signature demonstrated loss of H2BK5Ac in TSKI4, 
TSshCBP and CL cells. These results highlight the importance of MAP3K4/CBP-
mediated acetylation of H2BK5 for maintenance of the TS cell epithelial phenotype.  
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Results 
TSKI4 Cells Exhibit Properties of Both Stemness and EMT 
In the presence of FGF4, TS cells maintain self-renewal as defined by the 
maintenance of cell division with multipotency (Niwa et al, 2005; Tanaka, 1998). 
TSKI4 cells lack MAP3K4 activity but are self-renewing and multipotent. When 
cultured in the presence of FGF4, TSKI4 cells expressed the TS cell markers Cdx2, 
Eomes, Esrrβ and FGFR2 at levels similar to TSWT cells (Figures 3.1A-D). Removal 
of FGF4 promoted the differentiation of TSKI4 cells into all trophoblast lineages 
similar to TSWT cells with the loss of expression of stem cell markers (Figures 3.1A-
D) and the gain of expression of trophoblast lineage markers including the giant cell 
marker PLI, the spongiotrophoblast marker Tpbpα, and the syncytiotrophoblast 
marker Gcm1 (Figures 3.1E-G). Developmental potency of these stem cells was 
established through the injection of GFP-labeled TSWT or TSKI4 cells into wild-type 
blastocysts. Both TSWT and TSKI4 cells produced chimeric conceptuses with similar 
frequencies (Figure 3.1H) and contributed selectively to the trophoblast lineages 
including the extraembryonic ectoderm, ectoplacental cone, and giant cells (Figures 
3.1I-N and 3.2A-H). These cells were not found in the embryo or in any ICM-derived 
extraembryonic tissue (Figures 3.1I-N).  
 TSKI4 cells also exhibit the molecular and cellular characteristics of EMT. TSWT 
cells grew with an epithelial morphology (Figure 3.1O), with strong peripheral E-
cadherin (Figure 3.1P) and cortical actin expression at cell-cell contacts (Figures 
3.1Q-R). In contrast, TSKI4 cells exhibited a polarized front-back end, mesenchymal 
morphology (Figure 3.1S). E-cadherin was significantly reduced in TSKI4 cells 
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(Figures 3.1T). Also, filamentous actin was observed at the leading edge of TSKI4 
cells (Figures 3.1U-V). Reduction of total E-cadherin in TSKI4 cells relative to TSWT 
cells was further validated by Western blotting (Figure 3.1W). Real-time quantitative 
RT-PCR (qRT-PCR) showed a modest increase in the expression of the 
mesenchymal markers vimentin and N-cadherin in TSKI4 cells, and Western blotting 
revealed a 2.9-fold and 2.2-fold increase in vimentin and N-cadherin protein 
expression respectively (Figures 3.2I and 3.2J). Differentiation of both TSWT and 
TSKI4 cells also increased vimentin and N-cadherin protein expression (Figure 3.2J). 
TSKI4 cells and 4-day differentiated TSWT cells exhibited a fourteen to sixteen-fold 
increase in invasiveness compared to TSWT cells (Figure 3.1X). Hyperinvasiveness 
of the TSKI4 cells was also seen, in vivo. Defective decidualization is induced by 
excessive trophoblast invasion (Norwitz et al, 2001). Compared to injection of TSWT 
cells (Figure 3.1Y), injection of TSKI4 cells into wild-type blastocysts resulted in 
defective decidualization consistent with the hyperinvasiveness of TSKI4 cells 
(Figures 3.1Z-BB). Cumulatively, these data demonstrate that TSKI4 cells are self-
renewing stem cells with properties of EMT including loss of E-cadherin and gain of 
invasiveness.  
Developmental EMT in TSWT Cells  
Removal of FGF4 promotes the differentiation of TS cells and increased 
invasiveness of trophoblasts through Matrigel-coated transwells (Figure 3.3A). The 
invasive population was largest at four days post FGF4 withdrawal (TINV) (Figure 
3.3A). Morphologically, TSWT cells cultured in FGF4 grew in tight epithelial sheets 
with actin localized around the cell periphery (Figures 3.3B-C). In contrast, TINV cells 
	  46 
isolated from the bottom of Matrigel-coated transwells exhibited mesenchymal cell 
characteristics with prominent actin stress fibers, filamentous actin and loss of E-
cadherin (Figures 3.3D-G). E-cadherin was more significantly reduced in TINV cells 
compared to four day differentiated trophoblasts (TDIFF) not selected for invasiveness 
(Figures 3.3F-G). Expression of the mesenchymal marker fibronectin was 
significantly increased and vimentin was also expressed in TINV cells (Figure 3.4A). 
These changes in invasiveness, morphology, and E-cadherin expression indicated 
that the TINV cells have undergone EMT. 
Induction of EMT in TSWT Cells by Ectopic Expression of Snail 
To induce EMT in TS cells, we ectopically expressed a defined inducer of 
EMT, the transcription factor Snail, in TSWT cells (TSSnail) (Cano et al, 2000). TSSnail 
cells exhibited a polarized, mesenchymal morphology with increased filamentous 
actin and mesenchymal markers vimentin and N-cadherin (Figures 3.3H-J and 
3.4B). A ten-fold increase in invasiveness compared to TSWT cells and loss of E-
cadherin showed Snail overexpression induced TS cell EMT (Figures 3.3K-L). 
TSSnail cells expressed TS stem cell markers and were able to differentiate into 
trophoblast lineages upon removal of FGF4 (Figures 3.4C-D). To identify 
transcription factors responsible for inducing EMT in TS cells, we compared the 
expression levels of eight transcription factors known to regulate EMT in other 
systems. FGF4 withdrawal from TSWT cells induced Snail message at four days of 
differentiation and in TINV cells suggesting that Snail is important for TS cell EMT 
(Figures 3.3M and 3.4E). The EMT-inducing transcription factors Slug and Twist 
were elevated in undifferentiated TSKI4 cells, but were not induced with differentiation 
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or invasion of TSWT cells (Figures 3.3N-O and 3.4E). Upregulation of Lef1 and Ets1 
were also detected in TSKI4 and TSSnail cells (Figures 3.3P-Q). Similar to Snail, Lef1 
was induced at four days of TSWT cell differentiation and in TINV cells (Figure 3.3P 
and 3.4E). Other known transcriptional regulators of EMT like Zeb1, Foxc2, and Gsc 
were not induced with EMT of TINV or TSKI4 cells (Figures 3.4F-H). 
Gene Expression Changes with the Acquisition of Trophoblast Invasiveness 
To identify genes related to the acquisition of invasiveness in trophoblast 
EMT, we measured gene expression changes in TINV cells compared to TSWT cells 
using genome-wide Agilent microarrays. With a Benjamini-Hochberg p-value <0.05, 
6641 genes exhibited a two-fold change in expression in TINV cells (Table S1, 
http://www.sciencedirect.com/science/article/pii/S1934590911001184). Since TINV 
cells were differentiated for four days, a component of the 6641 changed genes 
reflected differentiation-specific changes unrelated to the acquisition of invasiveness. 
When gene expression changes of TDIFF cells compared to TSWT cells were 
measured, 5706 genes exhibited altered expression by a minimum of two-fold 
(Table S1, http://www.sciencedirect.com/science/article/pii/S1934590911001184). 
Direct comparison of gene expression changes in TINV and TDIFF cells revealed that 
2359 genes had significantly different expression measured as a minimum 1.5-fold 
change with 80% of these genes being changed only in TINV cells (Table S2, 
http://www.sciencedirect.com/science/article/pii/S1934590911001184). Gene 
ontology (GO) analysis of the 2359 genes showed significant enrichment in 
canonical KEGG pathways regulating focal adhesions, actin cytoskeleton, and 
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adherens junctions (Figure 3.5A). These findings define an invasive gene signature 
for trophoblast EMT.   
Gene Expression Changes in TSKI4 Cells  
Unlike TINV cells that have undergone EMT but have lost stemness, TSKI4 
cells are self-renewing stem cells in EMT. TSKI4 cells serve as a useful model to 
distinguish between genes that mediate invasiveness and EMT. Gene expression 
profiling defined changes in TSKI4 cells compared to TSWT cells, identifying 1083 
significantly upregulated genes and 702 significantly downregulated genes by more 
than two-fold (Benjamini-Hochberg p-value <0.05) (Table S1, 
http://www.sciencedirect.com/science/article/pii/S1934590911001184). GO analysis 
of downregulated genes showed a significant enrichment in nine canonical signaling 
pathways (Figure 3.5B). The top three enriched signaling pathways included focal 
adhesions, ECM-interactions, and regulation of the actin cytoskeleton, the same 
pathways that were identified in the TINV signature.   
Comparison of TSKI4 and TINV Signatures Identify Genes Important for EMT 
Unsupervised hierarchical clustering of TSKI4, TINV and TDIFF cells showed a 
common gene set for TINV and TDIFF cells indicated by a node correlation coefficient 
of 0.82 (Figure 3.6A). This strong correlation reflects the significant changes in gene 
expression due to FGF4 removal and loss of stemness in TINV and TDIFF cells, as 
compared to TSKI4 cells, showing that TSKI4 cells are not differentiated cells. Venn 
diagrams of upregulated (Figure 3.6B) and downregulated (Figure 3.6C) genes 
highlight the significant intersection between TDIFF and TINV cells, while demonstrating 
the limited intersection of 416 genes between TSKI4 and TINV cells. Significantly 
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changed genes were categorized according to biological function, and 25% of these 
genes regulate cell adhesion and motility including Lamb2, Fn1 and RhoB (Figures 
3.6D and 3.5C). In addition, genes were identified whose importance to invasion and 
EMT has not been previously defined, including the enrichment for genes regulating 
RNA splicing, transcription, translation, and protein degradation (Figure 3.5C). 
However, these genes must be functionally tested to prove their role in invasion and 
EMT. Using qRT-PCR, we validated the expression changes of several genes 
showing similar changes in TSKI4 and TINV cells (Figures 3.5D-E).  
Acetylation of Specific H2A and H2B Lysines Is Inhibited in TSKI4 Cells 
Induction of differentiation by FGF4 removal from TSWT cells was 
accompanied by reduced acetylation of all core histones, specifically at H2AK5, 
H2BK5/K12/K15/K20, H3K9, and H4K8 (Figure 3.7A). Trimethylation of H3K4 and 
H3K9 was unchanged with differentiation (data not shown). The differentiation-
induced loss of histone acetylation suggests the importance of histone acetylation in 
maintaining the undifferentiated epithelial state of TS cells. We therefore examined 
histone modifications in TSKI4 cells. Figure 3.7B shows the loss of acetylation at 
H2AK5, H2BK5, H2BK12, and H2BK15 in TSKI4 cells compared to TSWT cells. 
H3K9Ac and H4K8Ac were unaffected demonstrating that loss of histone acetylation 
was selective for H2A and H2B. Examination of histone methylation showed that 
trimethylation of H3K4 and H3K9 was not altered, suggesting that loss of H2A and 
H2B acetylation (H2A/H2BAc) in TSKI4 cells occurs independently of changes in 
histone methylation (Figure 3.7C). Examination of TSSnail cells that exhibit properties 
of stemness and EMT similar to TSKI4 cells revealed the selective loss of 
	  50 
H2A/H2BAc with no change in H3 and H4 acetylation (Figure 3.7D). These data 
show the association of loss of H2A/H2BAc with changes characteristic of EMT 
while maintaining stemness in TSKI4 cells.  
Reduction of H2BK5Ac on Select Gene Promoters in TSKI4 cells 
We used ChIP-seq to identify genes associated with the epigenetic mark 
H2BK5Ac during TS cell reprogramming important for the induction of EMT.  After 
obtaining DNA samples by ChIP using a highly specific H2BK5Ac antibody (Figures 
3.8A-B), we generated a total of 44 and 27 million Illumina sequence reads for TSWT 
and TSKI4 cells, respectively, consistent with Western blotting data (Figure 3.7B). 
This genome-wide analysis of the read-tag distribution demonstrated that H2BK5Ac 
is significantly enriched near the transcription start sites (TSS) of 13625 genes in TS 
cells (Figure 3.9A and Table S3, 
http://www.sciencedirect.com/science/article/pii/S1934590911001184). This 
H2BK5Ac peak location profile near the TSS is consistent with published studies in 
CD4+ T cells (Wang et al, 2008). 
 Limiting the analysis to the well-annotated RefSeq gene set (NCBI37/mm9), 
we compared the read tag density between TSWT and TSKI4 cells within 1kb 
upstream and downstream of the TSS. We normalized read-tag counts based upon 
the ratio of genome-wide total mapped reads between TSWT and TSKI4 cells. We 
removed background regions by filtering genes whose read tag counts did not 
significantly exceed cell-type specific background noise (<20 read tags per 2kb 
region). After removing duplicate genes, 4163 genes were significantly different in 
H2BK5Ac between TSWT and TSKI4 cells, as determined by the exact rate ratio test 
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with Benjamini-Hochberg adjusted p-value < 0.05. From the 4163 genes with a 
significant change in H2BK5Ac, 3515 genes had a significant loss of H2BK5Ac, 
while 648 genes had a significant gain of H2BK5Ac in TSKI4 compared to TSWT cells 
(Figures 3.9B-C). 
 Changes in H2BK5Ac were visualized by normalized read tag density plots. 
We demonstrated the dramatic loss of H2BK5Ac in TSKI4 cells for a select set of 
genes including Acsl6, Dbndd2, Itgav, Krt19 and Trim54 (Figures 3.9D and 3.8C).  
These are examples of genes with a highly significant loss of H2BK5Ac (i.e. 
Benjamini-Hochberg p-values <10-18) and occur in the top 3% of affected genes. 
Loss of H2BK5Ac in TSKI4 compared to TSWT cells was confirmed by ChIP-qRT-PCR 
(Figure 3.9E) and correlated with the loss of gene expression (Figure 3.5E). 
Furthermore, Acsl6, Itgav, Lamb2 and Trim54 demonstrated a similar loss of 
H2BK5Ac in TINV cells by ChIP-qRT-PCR, suggesting the importance of these genes 
in regulating the EMT program that occurs during trophoblast differentiation (Figure 
3.9E).  Although the majority of genes had a loss of H2BK5Ac in TSKI4 compared to 
TSWT cells, 648 genes had an increase in H2BK5Ac density in TSKI4 cells.  
Normalized density plots of Dkk3 and Mycn highlight two genes with a significant 
increase in H2BK5Ac (i.e. Benjamini-Hochberg p-values < 10-12) and a coordinate 
increase in gene expression in TSKI4 cells (Figure 3.9F and Tables S1 and S3, 
http://www.sciencedirect.com/science/article/pii/S1934590911001184).  
Consistent with the maintenance of TS cell multipotency, enrichment of 
H2BK5Ac occurs at the promoters of the TS cell markers Cdx2, Eomes, and Fgfr2 
(Figure 3.9G). As indicated from normalized promoter density plots, Eomes and 
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Esrrβ demonstrated unchanged levels of H2BK5Ac between TSWT and TSKI4 cells, 
while Cdx2 and Fgfr2 demonstrate a 50% decrease in H2BK5Ac density (Figure 
3.9G). H2BK5Ac levels were validated by H2BK5Ac ChIP-qRT-PCR for the Eomes 
and Cdx2 promoters (Figure 3.8D).   
Loss of H2BK5Ac Correlates with Repression of Genes Critical to Maintenance 
of the TS Cell Epithelial Phenotype 
Using mRNA-seq to quantitatively compare the changes in H2BK5Ac with the 
changes in gene expression for TSWT and TSKI4 cells, there was a modest positive 
correlation between changes in gene expression and H2BK5Ac, as determined by a 
Pearson correlation coefficient of 0.62 (p-value <10-16) (Figure 3.9H). This finding 
was further supported by GO analysis of genes both significantly downregulated and 
hypoacetylated showing shared gene changes important for maintenance of focal 
adhesions, the actin cytoskeleton, and extracellular matrix interactions (Figure 3.5B 
and Figure 3.8E). Collectively, these results highlight the importance of H2BK5Ac in 
regulating the active gene transcription program of TS cells, whereby loss of 
H2BK5Ac results in repression of genes critical to maintenance of the epithelial 
phenotype. 
TSKI4 Cells and Claudin-low Breast Cancer Share EMT Properties 
Recent studies have shown that the CL subtype of triple negative breast 
cancer exhibits both mesenchymal and stem-like properties (Prat et al, 2010; 
Hennessy et al, 2009). Compared to the four other breast tumor subtypes (i.e. 
Luminal A, Luminal B, HER2-enriched and Basal-like), CL tumors have the lowest 
expression of epithelial differentiation markers CD24, EpCAM, KRT7/19 and the cell 
	  53 
adhesion proteins CLDN3/4/7 and CDH1, while exhibiting highest expression of the 
mesenchymal markers VIM, N-cadherin, SNAI2 and TWIST1 (Prat & Perou, 2011; 
Prat et al, 2010). Hierarchical clustering of 22 genes characteristic of EMT and 
stemness from gene expression data of TSKI4 cells and 52 breast cancer cells lines 
reported by Neve et al. revealed that TSKI4 cells clustered most closely with the CL 
breast cancer subtype (Figure 3.10A) (Neve et al, 2006). Similar to the CL cell lines, 
TSKI4 cells exhibited an increase in the mesenchymal markers VIM, CDH2, SNAI2 
and TWIST1 with loss of the epithelial differentiation and cell adhesion markers 
CD24, KRT7/8/19 and CLDN4 (Figure 3.10A). Next, we examined the intersection 
between genes with unique Entrez identifiers from gene array data of CL cell lines 
compared to gene array data of TSKI4 cells. The intersection between upregulated 
and downregulated genes in the CL cell lines compared to TSKI4 cells was 
determined to be significant with 62 upregulated (p-value < 0.005) and 31 
downregulated (p-value < 0.01) overlapping genes (Figure 3.10B). This overlapping 
gene set was plotted on the basis of log2 ratio values from TSKI4 cells to demonstrate 
gene expression changes of the intersecting TSKI4/CL cell EMT gene signature 
(Figure 3.10C). Genes important for the induction of the mesenchymal phenotype, 
such as CDH2, DKK1, MET, PDGFRβ, SNAI2, TIMP2, THY1, TWIST1 and VIM 
were significantly upregulated, while genes important for maintenance of the 
epithelial phenotype and cell adhesion, such as AIM1, BCAM, KRT7, KRT19 and 
RAB25, were repressed (Figure 3.10C). In addition to these known regulators of 
EMT, this significant genetic intersection between two distinct EMT models with 
stem cell characteristics highlights a gene set important for both EMT and stemness.  
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Epigenetic Repression of TSKI4/CL EMT Genes by Reduction of H2BK5Ac  
TS cell EMT models, TSKI4 and TSSnail, demonstrated selective loss of histone 
H2A/H2BAc (Figures 3.7D). By H2BK5Ac ChIP-qRT-PCR, we examined the levels 
of H2BK5Ac on 32 downregulated genes that have overlapping gene expression 
profiles between CL SUM159 and TSKI4 cells and are known to have a significant 
loss of H2BK5Ac in TSKI4 cells by ChIP-seq (Figures 3.10C and Table S3, 
http://www.sciencedirect.com/science/article/pii/S1934590911001184). Of the 32 
genes tested by H2BK5Ac ChIP-qRT-PCR, 75 percent of these genes were 
validated to have a loss of H2BK5Ac and a coordinate loss of gene expression in 
TSKI4 compared to TSWT cells (Figure 3.10D and Figures 3.11A-C). Furthermore, 81 
percent of these genes had a similar loss of H2BK5Ac in TSSnail cells (Figure 3.10D 
and 3.11B-C). Due to the significant genetic intersection between CL cell lines and 
the TSKI4 EMT model, we determined the levels of H2BK5Ac on the promoters of the 
same 32 overlapping genes in the CL SUM159 cell line. Importantly, 80 percent of 
these genes had a loss of H2BK5Ac in SUM159 cells compared to human mammary 
epithelial cells (HMECs), as determined by ChIP-qRT-PCR (Figure 3.10E and 
3.11D-E). These results suggest that loss of H2BK5Ac represses genes with an 
important role in maintenance of the epithelial phenotype, thereby contributing to the 
progression of two distinct EMT programs. 
The pathological significance of the TSKI4/CL association was further 
emphasized by comparing the gene expression profile of TSKI4 cells to the five 
intrinsic molecular subtypes of breast tumors cataloged in the UNC337 data set 
(Prat et al, 2010). Tumors from the CL breast cancer subtype showed highest 
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expression of the TSKI4 gene expression signature compared to the Basal-like, 
HER2-enriched, Luminal A and Luminal B breast tumors (Figure 3.10F). Further 
analysis of the overlapping gene expression profiles in CL human tumors and TSKI4 
cells demonstrated a highly significant intersection between the gene array profiles 
of TSKI4 cells and CL human tumors (p-value < 0.0001 for upregulated genes) 
(Figure 3.10G). Although the intersection between the downregulated genes from 
TSKI4 cells and CL human tumors consists of only 13 genes, approximately 50 
percent of these genes AIM1, IRX5, KRT7, KRT19, RAB25 and SCYL3 were 
present in the intersecting TSKI4/CL EMT gene signature; these same genes also 
exhibited a coordinate loss of H2BK5Ac in TSKI4 and CL cells (Figure 3.10D). These 
findings highlight the importance of H2BK5Ac on genes whose repression is 
important for EMT in both developmental stem cell and metastatic human tumor 
models of EMT with stem cell properties.     
MAP3K4 regulates CBP acetylation of H2A and H2B  
Previously, we showed the requirement of MAP3K4 kinase activity for neural 
tube, skeletal, and placental development (Abell et al, 2005; 2009). We 
systematically examined the MAP3K4 signaling network for genes whose targeted 
disruption resulted in phenotypes similar to that of KI4 mice (Table 3.1). Strikingly, 
the genes overlapping most closely with the developmental defects observed with 
loss of MAP3K4 kinase activity were the histone acetyltransferase (HAT) CBP and 
its closely related family member p300. This phenotypic overlap suggested that the 
loss of H2A/H2BAc in TSKI4 cells may be related to altered CBP and/or p300 HAT 
activity. Nuclear extracts isolated from TSKI4 cells have significantly diminished HAT 
	  56 
activity relative to TSWT cells (Figure 3.12A). Total CBP and p300 protein expression 
was unchanged in TSKI4 cells (Figure 3.13A). MAP3K4-dependent JNK 
phosphorylation of CBP and p300 increased HAT activity, which was blocked by the 
JNK inhibitor SP600125 (Figures 3.12B and 3.13B). TSKI4 cells have a strongly 
diminished JNK activity (Abell et al, 2009), consistent with MAP3K4-dependent JNK 
activation regulating CBP/p300 HAT activity. Co-expression of MAP3K4 and JNK 
resulted in a 17.8 and 8.3-fold increase in the phosphorylation of CBP and p300, 
respectively (Figures 3.12C and 3.13C). CBP/p300 phosphorylation was JNK 
dependent, as p38 activation did not significantly alter phosphorylation of CBP or 
p300 (Figures 3.12C and 3.13C). To determine if CBP or p300 regulate 
endogenous TS cell functions, we infected TSWT cells with shRNAs to either CBP or 
p300. We achieved greater than 85% knockdown of CBP or p300 with three to four 
individual shRNAs for each (Figures 3.12D-E and data not shown).  Unlike control 
virus infected cells (Figure 3.12F), loss of CBP resulted in a dramatic change in 
morphology with TSshCBP cells exhibiting a front-back end polarized morphology 
(Figures 3.12G-H). In contrast, cells with loss of p300 maintained a normal epithelial 
morphology (data not shown). Compared to control virus infected cells, stemness 
markers in TSshCBP cells were unchanged for Eomes and FGFR2 and decreased by 
25% for Cdx2 and Esrrβ (Figure 3.13E). Further, expression of the mesenchymal 
marker vimentin was increased at both the level of message and protein in TSshCBP 
cells (Figure 3.13F and data not shown). Most importantly, TSshCBP cells exhibited a 
five to fifteen-fold increase in invasiveness as compared to control virus infected 
cells (Figure 3.12I). Changes in morphology and the expression of mesenchymal 
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markers combined with increases in invasiveness suggest that loss of CBP in TSWT 
cells induces EMT. Examination of histone acetylation in TSshCBP cells revealed the 
selective and specific loss of H2A/H2BAc (Figure 3.12J). In contrast, loss of p300 
resulted in a reduction in H3 and H4 acetylation, but did not affect H2A/H2BAc 
(Figure 3.12K). These data strongly suggest that CBP is the primary HAT that 
regulates H2A/H2BAc in TS cells and that the loss of H2A/H2BAc is sufficient to 
induce EMT in TS cells. 
 Genes downregulated in the TSKI4/CL EMT gene signature were similarly 
decreased in TSshCBP cells (Figure 3.13G). Because TSshCBP cells exhibit the 
selective loss of H2A/H2BAc acetylation similar to TSKI4 and TSSnail cells, (Figures 
3.7D and 3.12J), we used H2BK5Ac ChIP-qRT-PCR to measure H2BK5Ac on 
downregulated genes from the intersecting TSKI4/CL gene profile (Figure 3.13G).  Of 
these genes, 72 percent demonstrated a loss of H2BK5Ac in TSshCBP cells compared 
to control virus-infected cells (Figure 3.13H). These data show the coordinate loss 
of H2BK5Ac and gene expression in CL, TSKI4, TSSnail, and TSshCBP cells. Together, 
these findings show the importance of CBP-mediated H2BK5Ac in maintaining the 
epigenetic landscape important for the epithelial phenotype of TS cells. 
 
 
Discussion 
 
We have shown MAP3K4 dependent activation of JNK in response to FGF4 
controls CBP activity for the maintenance of the TS cell epithelial phenotype (Figure 
3.14). Loss of MAP3K4 kinase activity in TSKI4 cells results in gain of EMT properties 
including reduced E-cadherin, and morphological changes characteristic of 
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mesenchymal cells and increased invasiveness. TSKI4 cells also retain stemness 
defined by self-renewal with the maintenance of multipotency. These properties of 
TSKI4 cells show a functional separation of FGF4 dependent control of epithelial 
maintenance and stemness, with MAP3K4 signaling being critical for the epithelial 
phenotype.  
TSKI4 cells exhibit the selective loss of H2A/H2BAc, whereas histone H3 and 
H4 acetylation was largely unaffected. Loss of H2BK5Ac is restricted to a select set 
of genes in TSKI4 cells whose expression is significantly reduced. Epithelial 
maintenance was also disrupted by CBP knockdown, causing the loss of 
H2A/H2BAc similar to that observed with TSKI4 cells. Loss of CBP expression 
induced a phenotype similar to TSKI4, including gain of invasiveness and EMT 
characteristics while maintaining stemness. Consistent with the novel role of CBP 
and H2BK5Ac in regulation of gene expression profiles important for the epithelial 
phenotype, H3K4me3 and H3K9me3 are unchanged in TSKI4 cells. Additionally, 
H3K27me3 has been shown as unimportant in TS cell differentiation (Rugg-Gunn et 
al, 2010). Thus, histone acetylation by CBP is a primary mechanism for maintenance 
of the epithelial phenotype of TS cells, whereby loss of H2BK5Ac results in EMT. 
This finding is consistent with the role for CBP in maintaining hematopoietic stem 
cell self-renewal (Rebel et al, 2002). In addition to direct inhibition of CBP HAT 
activity, it is possible that a secondary mechanism of regulation exists to target loss 
of H2A/H2BAc to select gene promoters, whereby changes in CBP phosphorylation 
controls interactions with transcriptional regulators of EMT (Shenghui et al, 2009). 
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 Ectopic expression of Snail has been used to induce EMT in different cell 
types, and overexpression of Snail in HMECs induced a mesenchymal phenotype 
with expression of specific stem cell markers (Mani et al, 2008). This phenotype is 
reminiscent of TSKI4 cells, which induce EMT while maintaining stemness. Stable 
expression of Snail in TS cells resulted in the selective loss of H2A/H2BAc and 
properties of EMT and stemness, similar to TSKI4 and TSshCBP cells. ChIP-qRT-PCR 
studies showed loss of H2BK5Ac on an overlapping set of genes for TSKI4, TSshCBP, 
and TSSnail cells, defining each as a unique model system for the epigenetic control 
of EMT in a self-renewing primary cell.  
In contrast to TSKI4, TSshCBP, and TSSnail cells, TINV cells have completed EMT, 
having fully lost their epithelial morphology, as evidenced by the increase in 
invasiveness and gain in the mesenchymal morphology associated with filamentous 
actin and increased expression of the mesenchymal marker fibronectin. TINV cells do 
not self-renew and have lost acetylation of all four core histones. Since TINV cells 
have completed EMT, TINV gene expression profiles probably lack the EMT initiators, 
instead showing the expression of EMT executors (Thiery et al, 2009). Compared to 
TINV cells, TSKI4, TSshCBP, and TSSnail cells are in an intermediate state of EMT, where 
they are not fully mesenchymal but exhibit properties of both EMT and stemness. 
TSKI4 cells are uniquely trapped in this intermediate EMT state prior to complete 
acquisition of the mesenchymal phenotype, which can still be induced by the 
removal of FGF4.  
TS cell EMT shares many key properties with neural crest and cancer cell 
EMTs including loss of E-cadherin, gain of front-to-back polarity, and increased 
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invasiveness (Yang & Weinberg, 2008). However, there are differences in marker 
expression among these different EMT models indicative of cell type and stage-
specific EMT. For example, mesenchymal markers such as vimentin and N-cadherin 
are differentially expressed in these different EMT models, with N-cadherin 
repression being required for neural crest EMT (Yang & Weinberg, 2008). Lamb2 is 
increased in hepatocyte EMT, but reduced in neural crest, CL, TINV, TSKI4 and TSSnail 
EMTs. Fibronectin is elevated in breast and gastric cancers and in TINV cells but 
reduced in TSKI4 and TSSnail cells. The critical property for each EMT model is 
increased invasiveness (Kalluri, 2009).  
 Finally, TSKI4 and CL human breast cancer cells share properties of stemness 
and EMT with a common gene expression profile also found in patient CL tumors. 
Intersecting genes with loss of expression had a correlative loss of H2BK5Ac in both 
TSKI4 and CL cells. Some of these genes have defined roles in maintenance of the 
epithelial phenotype such as Aim1, Rab25 and Galnt3 (Maupin et al, 2010; Ray et al, 
1997), but most of the shared genes in the TSKI4/CL intersecting list have not been 
characterized for their role in epithelial maintenance or EMT and should be analyzed 
in different EMT models. Discovery of how H2A/H2BAc controls maintenance of the 
epithelial TS cell phenotype provides unique insight into how signaling networks 
controlling tissue stem cell EMT can be used to define previously unrecognized 
genes contributing to cancer cell EMT. This discovery may lead to defining novel 
gene targets or combinations of targets whose inhibition can be used to selectively 
inhibit TICs.  
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*Note: Mouse chimera experiments were courtesy of Dr. Amy Abell. 
 
Figure 3.1:  TSKI4 Cells Deficient in MAP3K4 Activity Maintain Self-renewal, 
Multipotency, and Developmental Potency While Exhibiting Properties of EMT. 
(A-D) Expression of TS cell stemness genes in TSKI4 cells measured by qRT-PCR. 
(E-G) Maintenance of multipotency in TSKI4 cells demonstrated by induction of 
trophoblast differentiation markers measured by qRT-PCR. Differentiation was 
induced by FGF4 withdrawal for the indicated number of days. (H-N) Developmental 
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potency of TSWT and TSKI4 cells demonstrated by injection of GFP positive TSWT and 
TSKI4 cells into wild-type blastocysts. (H) Data shows the number of GFP positive 
chimeras per cell type injected expressed as a percent of total embryos examined. A 
and B are two independent TSKI4 cell clones. (I) Sites of incorporation of GFP 
positive TSWT and TSKI4 cells in E6.5 conceptuses. (J, K, and L) Three 
representative whole embryo E6.5 TSKI4 chimeras and (M) 18 µm section from E6.5 
TSKI4 chimera are shown. Black bar represents 100 µm. EPC, ectoplacental cone; 
EXE, extraembryonic ectoderm; GC, giant cells. (N) Representative E9.5 TSWT cell 
chimera. Red asterisks indicate location of embryos. (O-V) Mesenchymal phenotype 
of TSKI4 cells compared to epithelial morphology of TSWT cells. (O) Phase 
microscopy of TSWT cells. (P) Immunostaining with anti-E-cadherin antibody (red) 
shows strong staining around the cellular periphery in TSWT cells with nuclear DAPI 
stain (blue). (Q) Cortical actin staining (green) and nuclear DAPI stain (blue) in TSWT 
cells. (R) Enlarged inset of region indicated by arrow in (Q) showing peripheral 
cortical actin in TSWT cells. (S) Phase microscopy of TSKI4 cells. Black bar represents 
100 µm. (T) Relocalization and loss of E-cadherin (red) from the periphery of TSKI4 
cells with nuclear DAPI stain (blue). (U) Filamentous actin staining (green) and 
nuclear DAPI stain (blue) in TSKI4 cells. White bar represents 50 µm. (V) Enlarged 
inset of region indicated by arrow in (U) showing filamentous actin in TSKI4 cells. 
White bar represents 10 µm. White arrow indicates site for insets in (R) and (V). (W) 
Reduced protein expression of E-cadherin and vinculin in TSKI4 cells shown by 
Western blotting. (X) Invasion through Matrigel by undifferentiated TSWT cells (0), 
TSWT cells differentiated for four days by FGF4 removal (4), or two independent 
TSKI4 cell clones (A and B) cultured in the presence of FGF4. Fold change is relative 
to TSWT cells. (Y) Representative E9.5 decidua from blastocyst injected with TSWT 
cells. (Z-BB) Three representative E9.5 deciduas from blastocysts injected with TSKI4 
cells. Arrowheads indicate sites of defective decidualization. (A-G) and (X) represent 
the mean ± range of two independent experiments. 
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*Note: Mouse chimera experiments were courtesy of Dr. Amy Abell. 
 
Figure 3.2: Developmental Potency and Mesenchymal Properties of TSKI4 Cells  
(A-H) Developmental potency of TSWT and TSKI4 cells demonstrated by injection of 
GFP positive TSWT and TSKI4 cells into wild-type blastocysts. Representative 18 µm 
section from TSWT cell (A,B) or TSKI4 cell (C-H) E6.0 to E6.5 chimeras. (E-H) Serial 
sections through an E6.5 chimera generated by injection of GFP positive TSKI4 cells. 
EPC, ectoplacental cone; EXE, extraembryonic ectoderm; GC, giant cells. White bar 
equals 100 µm. (I) Increased expression of mesenchymal markers in TSKI4 cells 
relative to TSWT cells as measured by qRT-PCR. Data shows the mean ± range of 
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two independent experiments performed in triplicate. (J) Increased expression of 
mesenchymal markers in TSKI4 relative to TSWT cells and with trophoblast 
differentiation as measured by Western blotting with the indicated antibodies. Fold 
changes are relative to undifferentiated TSWT cells. Data shows representative blots 
from two independent experiments. 
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Figure 3.3: Differentiation of TSWT Cells Induces EMT. 
(A) Differentiation of TS cells results in increased invasiveness. Invasion through 
Matrigel by undifferentiated TS cells (0) or TS cells differentiated by FGF4 
withdrawal for the indicated number of days (2,3,4,5) is shown. Data are the mean ± 
range of two independent experiments performed in duplicate. Undifferentiated cells 
(B,C), or invasive cells isolated from the bottom of Matrigel-coated transwell 
chambers (D,E) plated on glass coverslips. (B,D) Cells were stained for actin (green) 
and nuclei (blue). (C,E) Actin staining alone shows peripheral cortical actin in 
undifferentiated cells (C) and filamentous actin in invasive trophoblasts (E). White 
bar represents 50 µm. (F) Reduced Cdh1 (E-cadherin) in invasive trophoblasts (TINV) 
compared to undifferentiated TS cells (TSWT) and TS cells differentiated for four days 
(TDIFF). Data normalized to TSWT samples represent the mean ± SEM of three 
independent experiments. (G) Reduced E-cadherin protein in TINV cells. (H) 
Mesenchymal morphology of TSSnail cells. Black bar represents 100 µm. (I) 
Filamentous actin staining (green) and nuclear DAPI stain (blue) in TSSnail cells. (J) 
Filamentous actin staining in TSSnail cells. (K) Increased invasiveness of TSKI4 and 
TSSnail cells relative to TSWT cells. (L) Reduced Cdh1 in TSSnail cells compared to 
TSWT cells. (M-Q) Expression changes of EMT-inducing genes in TSWT, TSKI4, and 
TSSnail cells. Data show the mean ± range of two independent experiments.  
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Figure 3.4: Expression of Stem and Mesenchymal Cell Markers, and EMT-
Inducing Transcription Factors in TINV, TSKI4, and TSSnail Cells  
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(A) Increased expression of mesenchymal markers in TINV cells relative to TSWT cells 
as measured by Western blotting with the indicated antibodies. Data shows 
representative blots from two independent experiments. (B) Increased expression of 
mesenchymal markers in TSSnail cells relative to TSWT cells as measured by qRT-
PCR. Data shows the mean ± range of two independent experiments performed in 
triplicate. (C) Expression of TS cell stemness markers in TSSnail cells relative to TSWT 
cells measured by qRT-PCR. Data shows the mean ± range of two independent 
experiments performed in triplicate. (D) Maintenance of multipotency in TSSnail cells 
demonstrated by normal induction of trophoblast differentiation markers 0 to 5 days 
after removal of FGF4. Changes in message relative to TSWT cells were measured 
by qRT-PCR. Data shows the mean ± range of two independent experiments 
performed in triplicate. (E) Expression of EMT-inducing transcription factors in TSWT 
and TINV cells measured by qRT-PCR. Data shows the mean ± range of two 
independent experiments. (F-H) Expression of indicated EMT-inducing transcription 
factors 0 to 5 days after differentiation of TSWT, TSKI4, and TSSnail cells measured by 
qRT-PCR.   Data shown are the mean ± range of two independent experiments. 
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Figure 3.5: Intersecting Gene Expression Changes in Focal Adhesion and 
Actin Cytoskeleton Pathways in TINV and TSKI4 Cells  
(A) Enrichment for focal adhesion GO category in TINV cells. Canonical KEGG 
pathways are plotted according to p-values of pathway enrichment. (B) Enrichment 
for focal adhesion and actin cytoskeleton GO categories in TSKI4 cells. The p-values 
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for canonical KEGG pathways are shown. (C) Diagram shows TINV cell log2 ratios for 
the intersecting 416 genes with TSKI4 cells categorized according to biological 
function. Red and blue indicate upregulated and downregulated genes, respectively. 
Circle diameter shows the relative difference in log2 ratios in TINV cells versus TSKI4 
cells; abs(TINV-TSKI4). (D,E) Validation of gene expression changes by qRT-PCR in 
TSWT, TSKI4, TDIFF, and TINV cells. Data represent gene expression changes relative 
to TSWT cells expressed as the mean ± range for two independent experiments. 
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Figure 3.6:  Gene Expression Profiling of EMT in TSKI4 Compared to TINV Cells 
(A) Loss of MAP3K4 activity in TS KI4 cells results in significant changes in gene 
expression. Heat map compares gene expression changes in TSKI4 cells (1785 
genes), TDIFF cells (5706 genes), and TINV cells (6641 genes) relative to TSWT cells. 
Significantly changed genes have a Benjamini-Hochberg p-value < 0.05 and log2 
ratio > abs(1). Arrowheads indicate overlapping genes. (B,C) Venn diagrams show 
the overlap of upregulated (B) and downregulated (C) genes in TSKI4 cells, TDIFF 
cells, and TINV cells. (D) 25% of the overlapping genes between TSKI4 and TINV EMT 
models control cell adhesion and motility. Diagram depicts TINV cell log2 ratios from 
(A) for genes that regulate adhesion and motility having shared changes between 
TSKI4 and TINV cells. Circle diameter depicts changes in TSKI4 cell log2 ratios. 
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Figure 3.7: Selective Loss of H2A and H2B Acetylation in Undifferentiated TSKI4 
Cells  
(A) Acetylation of histones H2A, H2B, H3 and H4 is decreased upon induction of TS 
cell differentiation. Western blotting of lysates from TSWT or TSKI4 cells differentiated 
for the indicated days is shown. (B,C) TSKI4 cells exhibit selective loss of acetylation 
on histones H2A and H2B and no change H3 methylation. (D) TSSnail cells exhibit 
selective loss of acetylation on histones H2A and H2B. (A-D) Results are 
representative of two to three independent experiments. 
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Figure 3.8: Validation of H2BK5Ac ChIP-seq Analysis  
(A) Validation of the H2BK5Ac antibody used for ChIP-seq. Specificity of anti-
acetylated H2BK5 antibody was measured by Western blotting of acid-extracted 
histone lysates from TSWT cells using anti-H2BK5Ac antibody. (B) Specificity of anti-
acetylated H2BK5 antibody by ChIP. Semi-quantitative RT-PCR for the promoter of 
the TS cell marker Cdx2 from ChIP samples isolated from TSWT or TSKI4 cells is 
shown.  Results are representative of three independent experiments. (C) Promoter 
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acetylation density plots of additional genes with significant loss of H2BK5 
acetylation. Comparison of normalized coverage depth of acetylation density within 1 
kb of the transcription start site (TSS) between TSWT and TSKI4 cells for indicated 
genes with p-values < 1.4e-14. The x-axis for each subplot is the distance to the TSS, 
and the y-axis is the normalized coverage depth. (D) Validation of H2BK5Ac 
enrichment on promoters of TS cell stemness markers, Cdx2 and Eomes using 
H2BK5Ac ChIP-qRT-PCR. Data represent the mean + range of two independent 
experiments performed in triplicate. (E) GO categories enriched for genes with 
altered H2BK5Ac in TSKI4 cells.  The p-values of canonical KEGG pathways are 
shown. 
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Figure 3.9: Reduction of H2BK5Ac on Select Promoters in TSKI4 Cells 
Contributes to Repression of the Epithelial Phenotype. 
(A) Peak H2BK5Ac density occurs within 1kb of the TSS. Plot depicts the distribution 
of read tags around the TSS of mouse RefSeq genes. Solid red line represents the 
read tag distribution density of all genes in TSWT cells, and dotted blue line 
represents TSKI4 cells. Data was pooled from two independent experiments 
sequenced in duplicate. (B) Loss of H2BK5Ac occurs near the TSS of 3515 genes in 
TSKI4 cells. Scatter plot of RefSeq genes with read tag counts above 20 reads per 
2kb for genes identified from H2BK5Ac ChIP-seq of TSWT (x-axis) and TSKI4 (y-axis) 
cells. Solid line represents the data normalization reference line for delineating 
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genes with significant read count differences between TSWT and TSKI4 cells. 
Significance is based upon Benjamini-Hochberg FDR adjusted p-value < 0.05. 
Green and red dots represent 3515 genes with a significant decrease and 648 
genes with a significant increase in read tag density between TSWT and TSKI4 cells, 
respectively. Gray dots represent all non-significantly changed genes. Dotted line is 
a 45o reference line. (C) Bar graph summarizes all genes in (B) with significantly 
altered H2BK5Ac density in TSKI4 cells. Data for (B and C) were pooled as described 
in (A). (D) Reduced H2BK5Ac near the TSS of specific genes in TSKI4 cells. Plots of 
H2BK5Ac density compare the normalized coverage depth (NCD) of read tags 
around the TSS for indicated genes with loss of H2BK5Ac (p-values < 1e-18) between 
TSWT and TSKI4 cells. The x-axis for each subplot is the distance to TSS, and the y-
axis is the NCD of read tags. (E) Validation of reduced H2BK5Ac on specific genes 
in both TSKI4 and TINV cells shown by ChIP qRT-PCR of TSWT, TSKI4 and TINV cells. 
Data show the mean ± range of two independent experiments performed in 
duplicate. (F) Genes with increased H2BK5Ac near the TSS in TSKI4 cells plotted as 
described in (D). (G) Plots of H2BK5Ac density comparing the NCD for stem cell 
markers between TSWT and TSKI4 cells. (H) Changes in H2BK5Ac correlates with 
altered gene expression in TSKI4 cells.  Scatter plot of 6722 RefSeq genes with read 
tag counts above 50 reads per 1kb for genes identified by H2BK5Ac ChIP-seq (x-
axis) and mRNA-seq (y-axis) in TSKI4 cells. Read tag counts were converted to log2 
ratio values for comparison. Solid red line represents the linear regression line of the 
data with a Pearson correlation coefficient of 0.62 (p-value < 10-16). Labeled dots are 
genes with a four-fold change in both mRNA abundance and H2BK5Ac enrichment. 
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Figure 3.10: TSKI4 Cells and Claudin-low Breast Cancer With Properties of EMT 
and Stemness Show Loss of H2BK5Ac on Shared Genes. 
(A) TSKI4 cells cluster with the CL subtype of breast cancer cells. Heat map 
compares expression of 22 breast cancer EMT genes in TSKI4 cells and 52 breast 
cancer cell lines. TSKI4 cell and CL breast cancer cluster is outlined in red. Red and 
green arrows indicate shared upregulated and downregulated genes respectively. 
(B) Venn diagram depicts the intersection between genes elevated and 
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downregulated in CL cell lines compared to TSKI4 cells. (C) Plot shows log2 ratios (y-
axis) of TSKI4 cells for intersecting genes depicted in (B). (D) Reduced H2BK5Ac on 
specific genes in both TSKI4 and TSSnail cells from the intersecting downregulated 
genes in (C) measured by qRT-PCR of ChIP samples is shown. (E) Reduced 
H2BK5Ac on specific genes in CL breast cancer lines compared to normal HMEC 
breast cells as measured by ChIP-qRT-PCR. (D,E) Data are the mean ± range of 
two independent experiments performed in duplicate. (F) CL human tumors show 
the highest expression of TSKI4 genes among breast cancer subtypes. Mean 
expression of TSKI4 cell upregulated genes across the subtypes of breast cancer in 
the UNC337 data set. p-value was calculated by comparing gene expression means 
across all subtypes using an ANOVA test. Each + represents a distinct tumor sample 
within the data set. (G) Venn diagram of intersecting genes elevated and 
downregulated in CL human tumors and TSKI4 cells.  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  78 
 
 
Figure 3.11: Reduced Gene Expression and H2BK5 Acetylation in Intersecting 
Gene Sets between TSKI4, TSSnail, and CL Cells  
(A) Validation of reduced expression of TSKI4/CL intersecting genes in TSKI4 cells 
relative to TSWT cells measured by qRT-PCR. (B-E) Validation of loss of H2BK5Ac 
on promoters of TSKI4/CL intersecting genes measured by H2BK5Ac ChIP coupled 
to qRT-PCR. Data shows loss of H2BK5Ac from shared set of genes between TSKI4, 
TSSnail, and CL cells. (A-E) Data represent the mean + range of two independent 
experiments performed in triplicate.	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Gene	   Skeletal Neural 
Tube 
Cranio-
facial 
Embryonic 
Lethality 
Growth 
Retardation 
Cardiac Ref. 
MAP3K4 + + + + + - 1,2,4 
CBP + + + + + - 11,12 
P300 + + - + + + 15 
TRAF4 + + - + - - 9 
GCN5 + + - + + - 3,7,13,14 
Dvl1/2 + + - + - + 5 
JNK1/2 - + - + + - 6,10 
TWIST - + + + + - 8 
P38IP - + - + + - 17 
AXIN + + - + + + 16 
PCAF - - - - - - 14 
 
Table 3.1: Phenotypic Similarity between MAP3K4 (KI4) and CBP/p300 -/- Mice 
Yellow indicates phenotypic overlap of the MAP3K4 (KI4) mouse with the knockout 
mice for the genes listed.  + indicates presence of the phenotype specified. -
indicates absence of the phenotype specified.  Table is based upon comprehensive 
literature review, as indicated by the references below. 
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Figure 3.12: CBP Expression Is Required for MAP3K4-dependent Regulation of 
the Epithelial Phenotype in TS Cells. 
(A) HAT activity is significantly decreased in TSKI4 cells. Activity of one or three µg of 
nuclear lysate isolated from TSWT or TSKI4 cells is measured. Significance of change 
in HAT activity was evaluated by an unpaired Student’s T-test, *p-value < 0.05. (B) 
MAP3K4/JNK increases HAT activity of CBP measured as incorporation of [3H]-
acetyl-CoA in counts per minute (CPM) in 293 cells co-expressing CBP with the 
constitutively active kinase domain of MAP3K4 or kinase-inactive (KI). Significance 
of change in HAT activity was evaluated by an unpaired Student’s T-test. ***p-value 
	  81 
< 0.001; *p-value < 0.05. Data represents the mean ± SEM of three independent 
experiments performed in triplicate. (C) MAP3K4 and JNK promote phosphorylation 
of CBP as measured by kinase assay. γ32P-ATP labeled proteins were visualized by 
autoradiography and quantified by phosphorimaging. Data are representative of two 
independent experiments. (D,E) qRT-PCR shows reduced expression of CBP and 
p300 in TSWT cells infected with unique shRNAs for CBP (D) or p300 (E) compared 
to control virus-infected cells (Vec). Data represents the mean ± range of two 
independent experiments performed in triplicate. (F, G, and H) shRNA knockdown of 
CBP results in loss of the epithelial phenotype. Phase microscopy shows 
morphology of control virus-infected cells (F) compared to mesenchymal morphology 
of cells expressing CBP shRNAs (G,H). Black bar represents 100 µm. (I) Increased 
invasiveness of shCBP expressing cells compared to control virus-infected cells. 
Data shown represents the mean ± range of two independent experiments 
performed in triplicate. (J,K) Selective loss of H2A/H2BAc in CBP knockdown cells. 
Western blotting of lysates from TSWT cells infected with control virus, four 
independent CBP shRNAs  (J) or two independent p300 shRNAs is shown. Results 
are representative of two independent experiments. 
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Figure 3.13: TSshCBP Cells Display Properties of EMT and Stemness with 
Reduced Expression and H2BK5 Acetylation of TSKI4/CL Intersecting Genes.   
(A) CBP and p300 protein expression levels are unchanged in TSKI4 cells relative to 
TSWT cells.  Western blots were performed on nuclear lysates from either TSWT or 
TSKI4 cells using anti-CBP or anti-p300 antibodies.  Results are representative of two 
independent experiments. (B) MAP3K4/JNK increases HAT activity of p300 
measured as incorporation of [3H]-acetyl-CoA in counts per minute (CPM) in 293 
cells co-expressing p300 with the constitutively active kinase domain of MAP3K4 or 
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kinase-inactive. Significance of change in HAT activity was evaluated by an unpaired 
Student’s T-test. **p-value < 0.01; *p-value < 0.05. Data represents the mean ± SEM 
of three independent experiments performed in triplicate. (C) MAP3K4 and JNK 
promote phosphorylation of p300 as measured by kinase assay. γ32P-ATP labeled 
proteins were visualized by autoradiography and quantified by phosphorimaging. 
Protein expression levels were monitored by Western blotting with the indicated 
antibodies. Data are representative of two independent experiments. (D) CBP and 
p300 HAT activity is required to selectively acetylate histones H2A and H2B as HAT 
deficient CBP and p300 mutants are unable to acetylate H2A and H2B. Western 
blots were performed using acid-extracted histone cell lysates from 293 cells 
expressing wild-type (WT) or HAT-inactive CBP (ED) and p300 (DY) and probed 
with the indicated anti-acetylated H2A and H2B antibodies. Results are 
representative of two independent experiments. (E) Expression of TS cell stemness 
genes in TSshCBP cells compared to control virus (Vec) infected cells measured by 
qRT-PCR. (F) Increased expression of mesenchymal markers in TSshCBP cells 
relative to control virus (Vec) infected cells as measured by qRT-PCR. (G) Reduced 
expression in TSshCBP cells of genes common to TSKI4, TSSnail and CL cells as 
measured by qRT-PCR. (H) Reduced H2BK5Ac on the promoters of the same 
genes in G shown by H2BK5Ac ChIP-qRT-PCR. (E-H) Data shows the mean ± 
range of two independent experiments performed in triplicate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  84 
 
 
 
Figure 3.14: Induction of EMT in TS cells Is Epigenetically Regulated by Loss 
of H2A/H2B Acetylation.  
Graphical summary demonstrating that inactivation of MAP3K4/CBP results in loss 
of H2A/H2B acetylation and the induction of the intermediate EMT state 
characterized by the simultaneous existence stemness and EMT properties. 
 
 
 
 
 
 
 
 
Chapter IV 
 
Chromatin Remodeler Smarcd3/Baf60c Induces EMT by Epigenetic Regulation 
of Non-Canonical WNT Signaling 
 
Introduction 
Epithelial-mesenchymal transition (EMT) is a reversible developmental 
process, whereby epithelial cells lose cell-cell adhesion and apical-basolateral 
polarity, while acquiring a mesenchymal front-back end polarity and increased 
cellular invasiveness (Thiery & Sleeman, 2006). During metastatic tumor 
progression, this fundamental developmental program becomes reactivated to 
confer tumor cells with enhanced migratory and invasive properties, thereby 
promoting intravasation and dissemination of malignant cancer cells into the 
bloodstream. The opposing process of mesenchymal-epithelial transition (MET) 
reestablishes the epithelial state, as demonstrated by formation of epithelial tissues 
and organs in development and by metastatic colonization of epithelial tumors to 
distant organs (Yang & Weinberg, 2008; Valastyan & Weinberg, 2011; Thiery et al, 
2009). By understanding the underlying molecular mechanisms contributing to EMT 
and the reverse process MET, new strategies may be developed for the prevention 
and treatment of metastatic cancer.  
Studies based on global gene expression profiling have identified five breast 
cancer subtypes (Luminal A, Luminal B, HER2-enriched, Basal-like and Claudin-low) 
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(Perou et al, 2000; Sørlie et al, 2001; Prat & Perou, 2011). Among them, the Basal-
like and Claudin-low subtypes largely consist of poor prognostic tumors with an 
estrogen receptor (ER)-negative, progesterone receptor (PR)-negative and HER2-
non-overexpressing phenotype (i.e. triple-negative). These breast tumors 
demonstrate a high propensity to metastasize to the lung and brain parenchyma 
(Fulford et al, 2007; Gaedcke et al, 2007; Banerjee, 2006). At the molecular level, 
Basal-like and Claudin-low tumors share similar gene expression patterns such as 
low expression of Luminal and HER2-enriched genes. The Basal-like subtype is 
characterized by high expression of proliferation- and basal/myoepithelial cell-
specific genes, including cytokeratins 5, 14 and 17, while the Claudin-low subtype is 
characterized by high expression of mesenchymal- and stem cell-related genes and 
low expression of epithelial features such as claudins 3, 4 and 7 (Prat et al, 2010; 
Hennessy et al, 2009; Rakha et al, 2008b). These gene expression profiles are 
indicative of differences in epithelial and mesenchymal cellular states between 
Basal-like and Claudin-low subtypes.  
We previously identified a statistically significant EMT gene signature	  shared 
by epithelial stem cells developmentally entering EMT and the Claudin-low subtype 
of triple negative breast cancer (Abell et al, 2011). Based on this EMT gene 
signature across development and breast cancer models, we hypothesized that the 
upregulated genes within the signature represent genes critical to the induction of 
EMT and maintenance of the mesenchymal cell phenotype. To test this hypothesis, 
we designed an RNAi screen to identify individual genes within the EMT signature 
responsible for maintaining the mesenchymal phenotype. We used SUM149 and 
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SUM229 Basal-like breast cancer cells that exist in culture as dual populations of 
EpCAM(-) and EpCAM+/high cells (Prat et al, 2010; Gupta et al, 2011; Proia et al, 
2011). The two populations have a common genetic background but different 
phenotypes that are distinguishable based upon EpCAM expression.  
Herein, we describe an RNAi screening approach that identified a novel set of 
genes important for establishing the mesenchymal phenotype of EpCAM(-) SUM149 
and SUM229 cells. Using this RNAi screening strategy, the SWI/SNF chromatin-
remodeling factor Smarcd3/Baf60c was identified a novel regulator of EMT. While 
siRNA-mediated knockdown of Smarcd3/Baf60c induced MET in mesenchymal 
EpCAM(-) SUM149 and SUM229 cells, expression of Smarcd3/Baf60c in human 
mammary epithelial cells (HMECs) promoted the reverse process of EMT. This EMT 
program was activated by Smarcd3/Baf60c-mediated epigenetic induction of Wnt5a 
and non-canonical WNT signaling. These results define a new epigenetic 
mechanism of EMT regulation through the Smarcd3/Baf60c-mediated induction of 
non-canonical WNT signaling.  
 
Results 
SUM149 and SUM229 Breast Cancer Cells Maintain Epithelial and 
Mesenchymal Populations 
SUM149 and SUM229 breast cancer cells maintain a consistent distribution 
of two distinct populations of EpCAM(-) and EpCAM+/high cells that profile by gene 
expression analysis as Claudin-low and Basal-like breast cancer subtypes, 
respectively (Prat et al, 2010). Lander and colleagues modeled the behavior of these 
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populations as a measure of phenotypic equilibrium in SUM149 breast cancer cells 
and concluded that EpCAM(-) cells give rise to EpCAM+/high cells (Gupta et al, 2011). 
Consistent with this conclusion, following separation of the two populations by 
fluorescence activated cell sorting (FACS), the EpCAM(-) population of SUM149 cells 
gives rise to EpCAM+/high cells. After 10 days in culture, the EpCAM(-) cells consist of 
two distinct populations containing 5-10% EpCAM+/high cells, while the EpCAM+/high 
SUM149 cells remained in the EpCAM+/high state (Figure 4.1A). Similarly, the 
EpCAM(-) population of SUM229 cells gives rise to EpCAM+/high cells with a frequency 
of 1-3 percent over 10 days, while the EpCAM+/high population remained in the 
EpCAM+/high state (Figure 4.1A). To rule out the possibility of intrinsic contamination 
following FACS with EpCAM and Cd49f antigens, the EpCAM(-) SUM149 cells were 
resorted 10 days following the initial sort of the parental population. After repeating 
FACS with the EpCAM(-) SUM149 cells, the EpCAM(-) population gave rise to 
EpCAM+/high cells with a similar frequency of 5-10 percent over 10 days (Figure 
4.1B). Based upon the purity of the sorted populations and a doubling time of 
approximately 24 hours for SUM149 and SUM229 cells, the number of EpCAM+/high 
cells within the sorted EpCAM(-) population is consistent with EpCAM(-) cells giving 
rise to EpCAM+/high cells. 
Further characterization revealed the mesenchymal versus epithelial 
characteristics of EpCAM(-) and EpCAM+/high cells, respectively. EpCAM(-) cells 
demonstrated a spindle-like mesenchymal morphology contrasting with the rounded, 
cobblestone epithelial morphology of the EpCAM+/high cells (Figure 4.1C). 
Immunofluorescence and Western blotting confirmed the absence of the epithelial 
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markers EpCAM and E-cadherin in EpCAM(-) SUM149 and SUM229 cells (Figure 
4.1C-E). EpCAM(-) but not EpCAM+/high cells expressed the mesenchymal markers 
fibronectin, N-cadherin and vimentin and had filamentous actin stress fibers 
consistent with a front-back end polarized mesenchymal phenotype (Figures 4.1D-E 
and 4.2A). When compared to the EpCAM+/high SUM149 and SUM229 cells, the 
EpCAM(-) cells had decreased mRNA expression for the epithelial differentiation 
markers E-cadherin and EpCAM, as measured by quantitative real-time PCR (qRT-
PCR) (Figure 4.2B and C) and increased expression of the mesenchymal markers 
N-cadherin, vimentin, TGFβ, and the EMT-inducing transcription factors Snail, Slug, 
and Twist (Figure 4.2B-E). Functionally, the EpCAM(-) SUM149 and SUM229 cells 
were 3- and 8-fold more invasive through growth factor-reduced Matrigel than the 
EpCAM+/high cells, respectively (Figure 4.1F).  Collectively, these results 
demonstrate that the epithelial EpCAM+/high and mesenchymal EpCAM(-) populations 
of SUM149 and SUM229 cells are morphologically and functionally distinct. The 
finding that the mesenchymal EpCAM(-) SUM149 and SUM229 cells give rise to 
epithelial EpCAM+/high cells was used to develop an RNAi screen to characterize 
genes within our EMT signature that are sufficient to induce EMT and MET.  
RNAi Screen Identifies Genes Important for EMT 
EpCAM(-) SUM149 and SUM229 cells were used in RNAi screens to identify 
genes important to EMT and maintenance of the mesenchymal phenotype (Figure 
4.3A). Four independent siRNA oligonucleotides were used for targeting upregulated 
genes within the EMT gene signature shared by epithelial stem cells 
developmentally entering EMT and Claudin-low breast cancer (Table 4.1) (Abell et 
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al, 2011). With the exception of Slug, Twist, vimentin and N-cadherin, these genes 
are uncharacterized with respect to EMT (Table 4.1).  
As proof-of-principle for the RNAi screening strategy, we silenced known 
EMT-inducing genes Snail and Slug and measured the increase in epithelial markers 
EpCAM and E-cadherin by immunofluorescence (Figure 4.4A and B). These 
experiments demonstrated that siRNA-mediated knockdown of Snail or Slug in the 
mesenchymal EpCAM(-) SUM149 cells resulted in increased EpCAM and E-cadherin 
expression, loss of the mesenchymal phenotype and gain of the epithelial phenotype 
within six days after transfection (Figure 4.4A-C). At six days post transfection 
GAPDH siRNA-treated EpCAM(-) cells had a background of less than 3 percent 
EpCAM or E-cadherin positive cells (Figure 4.4A and B). In contrast, dual 
knockdown of Snail and Slug resulted in 26 and 10 percent EpCAM or E-cadherin 
positive cells, respectively (Figure 4.4A-C). A highly significant 3-5-fold dynamic 
range of quantitative EpCAM and E-cadherin percent fluorescence intensity was 
observed when comparing individual wells of a 96-well plate with siRNA-mediated 
knockdown of Slug or Snail versus GAPDH (Figure 4.4A-C). Furthermore, FACS 
purity checks before each screen showed initially less than 0.5% contamination of 
the EpCAM+/high cells within the EpCAM(-) population, suggesting that the observed 
increases in EpCAM and E-cadherin were indicative of a transition from 
mesenchymal EpCAM(-) to epithelial EpCAM+/high cell state rather than outgrowth of a 
contaminating fraction (Figures 4.3B and 4.5A-B). Validation of the image analysis 
method was achieved by titrating set percentages of EpCAM+/high SUM149 cells into 
an EpCAM(-) background. The percent fluorescence of EpCAM and E-cadherin 
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measured by high-content image analysis closely recapitulated the titrated 
percentages (Figure 4.5C). Therefore, this robust RNAi screening strategy was 
used for identification of genes whose knockdown induces a mesenchymal to 
epithelial transition (MET) in EpCAM(-) SUM149 and SUM229 cells.   
The RNAi screen targeted 140 upregulated genes within the EMT gene 
signature and identified ten genes whose inhibition resulted in the morphological 
transition between mesenchymal EpCAM(-) and epithelial EpCAM+/high phenotypes in 
both SUM149 and SUM229 cells (Figures 4.3C, 4.6A-D, 4.7A-C and Table 4.1). 
Compared to GAPDH, siRNA-mediated knockdown of these ten EMT-regulatory 
genes demonstrated a statistically significant increase in the percent EpCAM and E-
cadherin cellular fluorescence (Figure 4.6A and B). The ten identified EMT-
regulatory genes included: Slug, Cdh2, Smarcd3/Baf60c, ABR, Rnf130, EphA4, Met, 
Ptprb, Fhl1 and RRAGD (Figure 4.6A-D; see Table 4.2 for gene functions). In 
addition to upregulation of EpCAM and E-cadherin protein expression, siRNA-
mediated knockdown of these EMT-regulatory genes induced a morphological 
change characterized by the acquisition of an epithelial, cobblestone morphology 
(Figure 4.6C and D).  
Of the ten EMT-regulatory genes identified in the phenotypic RNAi screen, 
Slug, Cdh2, Smarcd3/Baf60c, Fhl1, Rnf130 and RRAGD were upregulated in the 
mesenchymal EpCAM(-) cells relative to the epithelial EpCAM+/high SUM149 and 
SUM229 cells (Figure 4.8A). Deconvolution of siRNA oligonucleotide pools showed 
efficient knockdown of the EMT-regulatory target genes by at least two individual 
oligonucleotides, suggesting that increases in EpCAM and E-cadherin expression 
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were the result of on-target effects (Figure 4.8B). Functionally, knockdown of ABR, 
Cdh2, Smarcd3/Baf60c or Slug expression resulted in significant decreases in 
cellular invasiveness through growth factor-reduced Matrigel (Figure 4.8C and 
Table 4.2). Furthermore, RNAi against each of the ten EMT-regulatory genes 
induced a decrease in mRNA expression of the EMT-inducing transcription factors 
Snail and Slug (Figure 4.8D and E and Table 4.2). Based upon characterization of 
traditional EMT markers and cellular invasiveness, this RNAi-screening strategy 
effectively identified genes whose individual loss was sufficient to inhibit the 
mesenchymal phenotype of EpCAM(-) SUM149 and SUM229 breast cancer cells.	  
Smarcd3/Baf60c is a Novel Epigenetic Regulator of EMT  
 Smarcd3/Baf60c has the potential to affect a broad network of genes through 
its epigenetic-regulatory function as a member of the SWI/SNF chromatin-
remodeling complex (Ho & Crabtree, 2010; Lickert et al, 2004; Takeuchi et al, 2007; 
Forcales et al, 2011). FLAG-tagged Smarcd3/Baf60c was stably expressed in 
human mammary epithelial cells (HMECs) to determine its role in the regulation of 
EMT. HMECs expressing Smarcd3/Baf60c (D3-HMECs) demonstrated phenotypic 
changes indicative of EMT (Figure 4.9A). D3-HMECs lost their epithelial cell 
morphology and became mesenchymal-like, losing epithelial cell-cell adhesion 
markers EpCAM and E-cadherin and gaining expression of the mesenchymal 
marker vimentin (Figure 4.9A). Western blotting confirmed the loss of expression of 
the epithelial markers EpCAM and E-cadherin with gain of the mesenchymal 
markers fibronectin and vimentin (Figure 4.9B). Of the EMT-inducing transcription 
factors, Lef1 and Zeb2 gene expression levels were increased compared to empty 
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vector control HMECs (EV-HMECs) (Figure 4.9C). Furthermore, the epithelial cell-
cell adhesion genes E-cadherin, EpCAM, Krt7, Krt19, Cldn4 and Cldn7 were 
downregulated (Figure 4.9C). Notably, mRNA expression of the tight junction genes 
Cldn4 and Cldn7 was reduced 90 percent compared to EV-HMECs (Figure 4.9C). 
Similar to EV-HMECs, D3-HMECs when separated by FACS, profiled as a single 
cellular population according to the antigenic expression levels of epithelial 
differentiation markers EpCAM/Cd49f and breast cancer stem cell markers 
Cd44/Cd24. However, D3-HMECs demonstrated a preferential reduction in the 
epithelial integrin Cd49f and gain in the pro-metastatic glycoprotein Cd44 with no 
change in the pro-differentiation glycoprotein Cd24 when compared to EV-HMECs 
(Figure 4.9D). These results support the role of Smarcd3/Baf60c as an EMT-
inducing chromatin- remodeling factor that promotes the mesenchymal phenotype 
with loss of the epithelial phenotype.  
Smarcd3/Baf60c Induces a Claudin-low Gene Signature 
 Since Smarcd3 is a SWI/SNF chromatin-remodeling factor capable of 
epigenetically regulating the expression of a gene network, we performed gene 
arrays to measure expression changes in D3-HMECS relative to EV-HMECs. 
Additionally, we compared gene expression changes of D3-HMECS with Snail-, and 
Slug expressing HMECs (Snail-HMECs and Slug-HMECs) to define gene networks 
important for EMT. Hierarchical cluster analysis of gene array data from D3-, Slug-, 
and Snail-HMECs with respect to the 9-cell line Claudin-low predictor described by 
Prat et al., revealed that the gene expression profiles of D3-HMECs clustered 
similarly to the mesenchymal Claudin-low signature of human breast cancer (Figure 
	  94 
4.10A and B) (Prat et al, 2010). Conversely, the gene expression profiles of Slug- 
and Snail-HMECs demonstrated substantially less overlap (Figure 4.10A and B). Of 
the D3-, Slug-, and Snail-HMECs, D3-HMECs had the most significant gene 
intersection (p-value < 0.0001) with the Claudin-low signature sharing 7% 
upregulated and 13% downregulated genes (Figure 4.10B). D3- and Slug-HMECs 
also exhibited a significant gene intersection (p-value < 0.0001) with 41% 
upregulated and 18% downregulated shared genes, indicating that Smarcd3/Baf60c 
and Slug affect an overlapping EMT gene network (Figure 4.11A). To further 
emphasize the significance of the D3-HMEC/Claudin-low association, the gene 
expression profile of D3-HMECs was compared to the five intrinsic molecular 
subtypes of human breast tumors catalogued in the UNC337 dataset. Tumors from 
the Claudin-low subtype showed highest expression of the D3-HMEC signature in 
comparison with Basal-like, HER2-enriched, Luminal A and Luminal B tumors 
(Figure 4.10C). The differentiation predictor described by Prat et al, which uses 
gene expression profiles to determine the cellular relatedness to the normal breast 
epithelial differentiation hierarchy from mammary stem cells (MaSCs) to mature 
luminal cells, showed that D3-HMECs had the lowest differentiation score compared 
to Slug- and Snail-HMECs (Figure 4.10D) (Prat et al, 2010; Lim et al, 2009). This 
finding reveals that D3-HMECs are more similar to MaSCs and more importantly to a 
less differentiated mesenchymal, Claudin-low phenotype than Slug- and Snail-
HMECs. Collectively, these results demonstrate that Smarcd3/Baf60c induces an 
EMT gene expression program in HMECs similar to that of the Claudin-low breast 
cancer subtype.  
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Molecular characterization of the Smarcd3/Baf60c-induced EMT in HMECs 
showed a more profound phenotypic conversion than that of the Snail- or Slug-
induced EMT in HMECs. Morphological changes included a loss of cell-cell 
adhesions in D3-HMECs, whereas Snail- and Slug-HMECs maintained epithelial 
cell-cell adhesions through either E-cadherin or EpCAM expression (Figure 4.11B). 
Immunofluorescence, Western blotting and qRT-PCR analysis of D3- and Slug-
HMECs showed decreased E-cadherin and increased vimentin, N-cadherin and 
fibronectin expression (Figure 4.11B-D). Snail-HMECs had preferentially decreased 
EpCAM expression (Figure 4.11B-D). Both Snail- and Slug-HMECs had a 2-4-fold 
increase in Smarcd3/Baf60c mRNA expression (Figure 4.11D). Furthermore, Snail- 
and Slug-HMECs transcriptionally activated the EMT-inducing transcription factor 
Zeb2 similarly to Smarcd3/Baf60c (Figures 4.11E and 4.9C). Like D3-HMECs, Slug-
HMECs preferentially repressed the cell-cell adhesion tight junction genes Cldn4 
and Cldn7, possibly contributing to the disruption of epithelial cell polarity (Figure 
4.11E). Cumulatively, these findings suggest that Smarcd3/Baf60c and Slug might 
impact a similar EMT network. 
SWI/SNF Complex Regulates Non-Canonical WNT Signaling through 
Epigenetic Activation of Wnt5a 
Wnt5a is a well-known regulator of cell polarity and cell adhesion through 
activation of non-canonical WNT signaling (Veeman et al, 2003; Zhu et al, 2012; 
Dissanayake et al, 2007). Expression of Wnt5a, the primary WNT ligand controlling 
activation of the non-canonical WNT signaling network, was upregulated in at least 
two independent D3-HMEC cell lines (Figure 4.12A). Elevated Wnt5a expression in 
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Slug-HMECs and EpCAM(-) SUM149 and SUM229 cells further validates the 
importance of Wnt5a to the induction of EMT in three additional EMT cell models 
with upregulated Smarcd3/Baf60c expression (Figure 4.13A and B). Activation of 
non-canonical WNT signaling pathways in D3-HMECs was demonstrated by 
increased PKCβ phosphorylation and expression of TGFβ (Figure 4.12A and B). 
Meanwhile, nuclear recruitment of β-catenin was diminished in the D3-HMECs, 
suggesting the possible inhibition of canonical WNT signaling (Figure 4.12B).  
Smarcd3/Baf60c is a member of a multi-subunit SWI/SNF chromatin- 
remodeling complex. The ATP-dependent catalytic components of these complexes 
are either Brm or Brg1 (Ho & Crabtree, 2010; Bultman et al, 2000). In D3-HMECs, 
Brg1 was preferentially induced with Smarcd3/Baf60c expression, while Brm was 
unchanged (Figure 4.12C). Furthermore, Brg1 and FLAG-Smarcd3/Baf60c co-
immunoprecipitated (Figure 4.12D), consistent with Brg1 and Smarcd3/Baf60c 
interacting to form a complex. Brg1 is known to regulate transcription of E-cadherin 
and Cd44, so we used these genes as controls for chromatin immunoprecipitation 
(ChIP) assays to determine if the Brg1/Smarcd3/Baf60c complex resided on the 
Wnt5a gene promoter (Figure 4.12E) (Banine, 2005). ChIP assays with antibodies 
against Brg1 and/or Smarcd3/Baf60c demonstrated that Smarcd3/Baf60c and Brg1 
bound to the promoters of E-cadherin, Cd44 and Wnt5a genes but not the Cldn4 
gene (Figure 4.12E and F). Simultaneous ChIP assays for the activating histone 
methylation mark H3K4me3 demonstrated transcriptional repression of E-cadherin 
and Cldn4 with activation of Cd44 and Wnt5a (Figure 4.12G), demonstrating that 
Smarcd3/Baf60c and Brg1 contribute to the epigenetic activation of Wnt5a.  
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Inhibition of Wnt5a Restores Epithelial Adherens Junctions  
 To determine if Wnt5a was responsible for inducing the loss of epithelial 
characteristics resulting from Smarcd3/Baf60c expression, we inhibited Wnt5a 
expression using RNAi in D3-HMECs. siRNA-mediated knockdown of Wnt5a 
phenotypically converted mesenchymal-like cells lacking cell-cell adhesions to 
epithelial colonies with a cobblestone morphology (Figure 4.14A). Wnt5a 
knockdown resulted in the increased mRNA and protein expression of epithelial 
markers E-cadherin and EpCAM (Figure 4.14B and C). Although expression of 
epithelial tight junction genes Cldn4 and Cldn7 was reduced by 90 percent in D3-
HMECs relative to EV-HMECs (Figure 4.9C), knockdown of Wnt5a resulted in a 10-
fold increase in Cldn4 and Cldn7 (Figure 4.14B). Furthermore, the EMT-inducing 
transcription factor Lef1 and the mesenchymal marker vimentin, which were induced 
with Smarcd3/Baf60c expression (Figure 4.9B and C), were repressed with 
knockdown of Wnt5a (Figure 4.14B). Finally, knockdown of Wnt5a repressed PKCβ 
phosphorylation, consistent with inhibition of the non-canonical WNT signaling 
pathway (Figure 4.14C). Treatment of D3-HMECs with a Wnt5a blocking antibody 
inhibited cellular invasiveness by 70 percent compared to untreated D3-HMECs 
(Figure 4.14D), demonstrating that the phenotypic changes coincided with functional 
changes indicative of a more epithelial cell state. Functionally, the blocking antibody 
was as effective as siRNA-mediated knockdown of Wnt5a (Figure 4.14D). These 
results demonstrate that Smarcd3/Baf60c and Brg1 are members of a SWI/SNF 
chromatin-remodeling complex that promotes EMT through epigenetic regulation of 
Wnt5a expression.  
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Discussion 
 In this report, we describe a directed phenotypic RNAi screening strategy to 
identify individual genes whose siRNA-mediated knockdown is sufficient to promote 
MET in the mesenchymal EpCAM(-) population of SUM149 and SUM229 breast 
cancer cells. Although EMT has been accepted as a reversible process during 
development, few studies have examined the opposite process of mesenchymal-
epithelial transition (MET) during the progression of breast cancer (Kalluri & 
Weinberg, 2009; Valastyan & Weinberg, 2011). This phenotypic RNAi screening 
approach demonstrates the reversible nature of EMT and MET in SUM149 and 
SUM229 breast cancer cells. The RNAi screen targeted 140 genes from an EMT 
gene signature	   shared by epithelial stem cells developmentally entering EMT and 
Claudin-low breast cancer cells with properties of EMT and stemness (Abell et al, 
2011). Ten of the 140 genes were identified as EMT-regulatory genes, whose 
individual siRNA-mediated knockdown was sufficient to promote MET. Three of the 
genes, Slug, Met receptor tyrosine kinase and N-cadherin, are well-defined 
regulators of EMT and provide further validation of the screen (Thiery & Sleeman, 
2006). The other seven genes are not previously defined for having a functional role 
in cancer cell EMT, but the functions of many of these genes suggest importance in 
the phenotypic reprogramming associated with EMT. For instance, EphA4 and 
Ptprb/VE-Ptp represent a receptor tyrosine kinase and phosphatase, respectively, 
that in development have been defined to be critical regulators of angiogenesis 
(Holder & Klein, 1999; Pasquale, 2010; Dominguez et al, 2007; Mori et al, 2010). 
Fhl1 localizes to focal adhesions where it promotes cell spreading, and Rnf130 is a 
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ring finger protein with putative E3 ligase activity (Rafael et al, 2012; Maetzel et al, 
2009; Ding et al, 2009; Sheikh et al, 2008; Guais et al, 2006). Consistent with its 
knockdown inhibiting invasion of mesenchymal EpCAM(-) SUM149 cells, ABR is a 
GEF/GAP for Rho and Cdc42 GTPases, and RRAGD is a poorly characterized 
GTPase with homology to Ras (Chuang et al, 1995; Tcherkezian & Lamarche-Vane, 
2012; Sekiguchi, 2000; Sancak et al, 2010). Among these uncharacterized EMT-
regulatory genes, Rnf130 is an ideal gene candidate for future mechanistic studies 
with respect to EMT. Our preliminary findings have demonstrated that combined 
knockdown of Rnf130, Slug and Smarcd3/Baf60c produced synergistic effects in 
promoting an epithelial morphology in mesenchymal Claudin-low SUM159 breast 
cancer cells. Our data suggest these six EMT-regulatory genes in addition to Slug, 
Met, N-cadherin and Smarcd3/Baf60c are likely members of a signaling network 
controlling EMT.  
Herein, we demonstrate that Smarcd3/Baf60c is a novel epigenetic EMT-
regulatory gene. Smarcd3/Baf60c was the only gene identified in the RNAi screen 
whose knockdown strongly increased both EpCAM and E-cadherin expression, 
decreased Snail and Slug expression, inhibited invasiveness and was also 
upregulated in EpCAM(-) relative to EpCAM+/high SUM149 and SUM229 breast cancer 
cells. Smarcd3/Baf60c is a member of the multi-subunit ATP-dependent SWI/SNF 
chromatin-remodeling complex with the ability to epigenetically modulate gene 
expression programs (Lickert et al, 2004; Ho & Crabtree, 2010). Smarcd3/Baf60c 
induced an EMT gene expression program in HMECs similar to that of the Claudin-
low breast cancer subtype, indicating that Smarcd3/Baf60c plays an important role in 
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maintaining the EMT properties and mesenchymal phenotype of these cells.  
Consistent with their related roles as transcriptional regulators, siRNA-mediated 
knockdown of Slug induced a MET phenotype similar to inhibition of 
Smarcd3/Baf60c expression. Notably, ectopic expression of either Smarcd3/Baf60c 
or Slug similarly induced the expression of Wnt5a, suggesting that Smarcd3/Baf60c 
affect an overlapping EMT gene network. To our knowledge, this is the first report of 
Smarcd3/Baf60c promoting the epigenetic reprogramming events responsible for 
inducing EMT and for maintaining the mesenchymal phenotype in Claudin-low 
EpCAM(-) populations of two independent breast cancer cell lines.  
There is an expanding awareness that SWI/SNF chromatin-remodeling 
complexes play critical functions in reprogramming events relevant to EMT and 
lineage commitment. Brg1, one of the catalytic components of SWI/SNF chromatin-
remodeling complex, is important in the reprogramming of somatic cells to induced 
pluripotent stem (iPS) cells (Singhal et al, 2010; Kidder et al, 2009). MET was shown 
recently to occur simultaneously with the reprogramming of fibroblasts to iPS cells, 
directly connecting MET to iPS cell generation (Li et al, 2010). Our results indicate 
that studies are warranted to determine if Smarcd3/Baf60c expression is repressed 
in these cells as a switch to induce MET during iPS cell reprogramming. In the 
context of regulating EMT and MET, the non-canonical WNT signaling pathway has 
been shown to be an important collaborator with TGFβ for inducing EMT. Non-
canonical WNT signaling, for example, contributes to the metastatic progression of 
pancreatic cancer and melanoma (Scheel et al, 2011; Yu et al, 2012; Dissanayake 
et al, 2007). In D3-HMECs, we showed that both Smarcd3/Baf60c and Brg1 bind the 
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promoters of Wnt5a and E-cadherin. Wnt5a expression is induced, stimulating non-
canonical WNT signaling, while E-cadherin expression is repressed to promote 
EMT. Together, these findings show the importance of Smarcd3/Baf60c in 
controlling the commitment to the mesenchymal cellular phenotype.  
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Figure 4.1: SUM149 and SUM229 Breast Cancer Cells Maintain Epithelial and 
Mesenchymal Populations. 
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(A) FACS analysis of SUM149 and SUM229 cells showing two EpCAM(-) and 
EpCAM+/high populations. (B) Serial FACS analysis of SUM149 EpCAM(-) cells 
demonstrating conversion from EpCAM(-) to EpCAM+/high cells after two repeated 
FACS experiments. (C) Epithelial and mesenchymal properties of EpCAM(-) and 
EpCAM+/high populations shown by phase microscopy and immunostaining with 
nuclear DAPI stain and anti-E-cadherin and anti-EpCAM antibodies. (D-E) Reduced 
EpCAM and E-cadherin protein expression with elevated fibronectin, N-cadherin and 
vimentin protein in EpCAM(-) cells. (A-E) Data are representative of at least two 
independent experiments. (F) Increased invasiveness of mesenchymal EpCAM(-) 
compared to epithelial EpCAM+/high cells. Statistical significance was evaluated by an 
unpaired Student’s T-test. ***p-value < 0.001; **p-value < 0.01. Data are the mean + 
range of two independent experiments performed in triplicate.  
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Figure 4.2: Characterization of Epithelial and Mesenchymal Populations in 
SUM149 and SUM229 Cells 
(A) Filamentous actin stress fibers in EpCAM(-) cells compared to cortical actin in 
EpCAM+/high cells as shown by immunostaining with nuclear DAPI and rhodamine 
Phalloidin stains. (B-C) Reduced EpCAM and E-cadherin mRNA expression and 
elevated N-cadherin, vimentin and Tgfβ expression in EpCAM(-) compared to 
EpCAM+/high cells. (D-E) Elevated mRNA expression of EMT-inducing transcription 
factors Snail, Slug and Twist in EpCAM(-) compared to EpCAM+/high cells. (B-E) Data 
are the mean + range of three independent experiments performed in triplicate. 
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Figure 4.3: RNAi Screening Strategy for EMT-Regulatory Genes 
(A) Schematic depicting the RNAi screening strategy. (B) Separation of EpCAM+/high 
and EpCAM(-) SUM149 cells by FACS shows less than 0.5 percent EpCAM+/high 
contamination in the EpCAM(-) cells. Data depicts FACS analysis of three individual 
cell sorts used for the primary RNAi screen. (C) Representative plate image from the 
RNAi screen shows expression of epithelial markers E-cadherin and EpCAM by 
immunofluorescence in EpCAM(-) SUM149 cells following siRNA-mediated 
knockdown of target genes in duplicate wells shown in columns 2-11, rows A-H; 
siGAPDH in columns 1 and 12, rows B-D and E-H, respectively; siSnail/Slug in 
columns 1 and 12, rows E-H and A-D, respectively; and siUBB in wells A1 and H12. 
Data are representative of duplicate RNAi screens for 140 genes performed in 
triplicate. 
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Gene Symbol Gene ID Gene Accession GI Number Dhamacon Pool # 
MET 4233  NM_000245 42741654 M-003156-02 
PDGFRB 5159  NM_002609 68216043 M-003163-03 
PTPRB 5787  NM_002837 157952212 M-004994-03 
SYK 6850  NM_003177 34147655 M-003176-03 
HCK 3055  NM_002110 30795228 M-003141-03 
PDGFRA 5156  NM_006206 61699224 M-003162-04 
AXL 558  NM_001699 157779133 M-003104-03 
EPHA4 2043  NM_004438 45439363 M-003118-02 
EGFR 1956  NM_201283 41327733 M-003114-03 
RET 5979  NM_020630 126273513 M-003170-02 
VIM 7431  NM_003380 62414288 M-003551-02 
MBNL1 4154  NM_207294 46411167 M-014136-01 
PLAT 5327  NM_033011 132626641 M-005999-01 
CDH2 1000  NM_001792 14589888 M-011605-01 
FHL1 2273  NM_001449 34147646 M-015857-00 
THY1 7070  NM_006288 19923361 M-015337-00 
SERPINB1 1992  NM_030666 20149554 M-016240-00 
TIMP2 7077  NM_003255 73858577 M-011793-01 
DKK3 27122  NM_001018057 66346688 M-018352-01 
ABR 29  NM_001092 38679953 M-008611-00 
SLIT2 9353  NM_004787 4759145 M-019853-01 
MCAM 4162  NM_006500 71274106 M-003686-01 
DIXDC1 85458  NM_033425 116256346 M-007758-01 
ELMO1 9844  NM_001039459 86788139 M-012851-01 
KLF2 10365  NM_016270 49574523 M-006928-01 
DKK1 22943  NM_012242 61676924 M-003843-01 
SLIT3 6586  NM_003062 11321570 M-012600-00 
VAV1 7409  NM_005428 7108366 M-003935-01 
SOX17 64321  NM_022454 145275218 M-013028-01 
SOX11 6664  NM_003108 30581115 M-017377-02 
CITED1 4435  NM_004143 20127458 M-016022-00 
RAB27A 5873  NM_004580 34485707 M-004667-00 
SMARCD3 6604  NM_001003802 51477703 M-009459-02 
ARHGEF6 9459  NM_004840 22027524 M-010231-00 
HEY1 23462  NM_012258 105990527 M-008709-02 
CCDC50 152137  NM_174908 33186926 M-017781-01 
HIC 29969  NM_199072 110735446 M-025441-01 
METRNL-
LOC284207 
284207  NM_001004431 52345386 M-022983-01 
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PHACTR2 9749  NM_001100166 154354971 M-020445-02 
TSPAN-2 10100  NM_005725 58331193 M-017266-01 
GNG11 2791  NM_004126 91807126 M-016036-01 
LY96 23643  NM_015364 34098964 M-020298-00 
RAFTLIN 23180  NM_015150 41872576 M-023452-01 
DPYSL2 1808  NM_001386 50811906 M-009519-01 
AKAP12 9590  NM_005100 21493021 M-010232-00 
CTSC 1075  NM_001814 22538438 M-005835-03 
KHDRBS3 10656  NM_006558 5730072 M-012748-00 
LDHB 3945  NM_002300 142386935 M-009779-01 
PTPRM 5797  NM_002845 157419149 M-006326-01 
MMP9 4318  NM_004994 74272286 M-005970-03 
DPYSL3 1809  NM_001387 4503378 M-009821-00 
ITM2A 9452  NM_004867 74316000 M-019433-01 
RGL1 23179  NM_015149 93102366 M-008387-01 
CTSH 1512  NM_148979 148536856 M-005839-01 
ELK3 2004  NM_005230 4885202 M-010320-00 
NEXN 91624  NM_144573 148839338 M-016402-01 
JAM2 58494  NM_021219 21704284 M-017389-00 
AMICA 120425  NM_001098526 148664206 M-016407-01 
CORO1A 11151  NM_007074 68161542 M-012771-01 
CD93 22918  NM_012072 88758612 M-007815-02 
FBLN2 2199  NM_001998 51873054 M-011655-01 
STX11 8676  NM_003764 33667037 M-019469-01 
HEM1 3071  NM_005337 153792638 M-019219-01 
PPAP2B 8613  NM_003713 29171739 M-017312-01 
RNF130 55819  NM_018434 38176162 M-007021-00 
ARHGEF6 9459  NM_004840 22027524 M-010231-00 
RASSF4 83937  NM_032023 30474868 M-017587-00 
CXCL12 6387  NM_000609 76563934 M-007873-01 
ICAM1 3383  NM_000201 4557877 M-003502-01 
ACSL4 2182  NM_004458 4758331 M-009364-00 
GADD45A 1647  NM_001924 9790904 M-003893-02 
NDRG1 10397  NM_006096 37655182 M-010563-01 
TBX3 6926  NM_005996 47419904 M-012197-00 
PCAF 8850  NM_003884 6382075 M-005055-00 
SFRP2 6423  NM_003013 52630413 M-024062-02 
NDRG2 57447  NM_016250 10280619 M-013858-00 
DACT1 51339  NM_001079520 118498363 M-016440-01 
SH3KBP1 30011  NM_031892 13994241 M-014748-00 
WAS 7454  NM_000377     
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SMARCA4 6597  NM_003072 21071055 M-010431-00 
MT2A 4502  NM_005953 31543214 M-018338-00 
PLP2 5355  NM_002668 4505892 M-019592-00 
COL5A1 1289  NM_000093 89276750 M-011015-01 
ANTXR1 84168  NM_018153 16933552 M-010679-00 
LIFR 3977  NM_002310 73486667 M-008017-01 
LAMP2 3920  NM_002294 4504956 M-011715-00 
LOXL2 4017  NM_002318 67782347 M-008020-01 
GYPC 2995  NM_002101 21614502 M-011680-00 
EPB41L3 23136  NM_012307 32490571 M-015330-00 
COL6A1 1291  NM_001848 87196338 M-011620-01 
HEXA 3073  NM_000520 119395761 M-011049-01 
ABCC4 10257  NM_001105515 157502202 M-007313-01 
TFPI 7035  NM_001032281 98991771 M-019922-01 
SLC2A3 6515  NM_006931 5902089 M-007516-01 
CLU 1191  NM_001831 42716296 M-019513-00 
CSPG4 1464  NM_001897 126091140 M-011632-01 
LARP6 55323  NM_197958 37537705 M-021333-00 
CHST2 9435  NM_004267 71067350 M-008963-01 
RCN3 57333  NM_020650 28626509 M-017962-01 
PVRL3 25945  NM_015480 11386198 M-013952-01 
DHRS8 51170  NM_016245 142976728 M-008859-01 
PMP22 5376  NM_153322 24430164 M-010616-02 
RIS1 25907  NM_015444 116805333 M-013960-01 
THBD 7056  NM_000361 40288292 M-012551-02 
PAG 55824  NM_018440 63054863 M-012956-02 
CYBA 1535  NM_000101 68509913 M-011020-01 
NT5E 4907  NM_002526 4505466 M-008217-00 
CLGN 1047  NM_004362 4758003 M-011830-00 
C1S 716  NM_001734 4502494 M-005796-01 
ITGA11 22801  NM_001004439 52485852 M-008000-02 
SMPD1 6609  NM_001007593 56117841 M-006676-01 
ST3GAL6 10402  NM_006100 31377787 M-018009-01 
PDLIM3 27295  NM_014476 7656882 M-020229-00 
CHST7 56548  NM_019886 23238227 M-008443-00 
MYO5A 4644  NM_000259 115511013 M-019321-01 
RRAGD 58528  NM_021244 142369198 M-016120-01 
RGS2 5997  NM_002923 142365756 M-009887-02 
MOXD1 26002  NM_015529 118421086 M-009446-02 
LIN7B 64130  NM_022165 56676320 M-009653-01 
AQP9 366  NM_020980 157266306 M-007768-02 
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RGS17 26575  NM_012419 56790938 M-009513-02 
MMP11 4320  NM_005940 58331147 M-005953-01 
FGF13 2258  NM_033642 16306542 M-011859-02 
GAS1 2619  NM_002048 4503918 M-011665-00 
PCDH18 54510  NM_019035 156630996 M-013372-01 
CMKOR1 57007  NM_020311 114155149 M-013212-03 
CCL2 6347  NM_002982 56119169 M-007831-01 
LDHC 3948  NM_017448 9257227 M-008759-02 
GDF6 392255  NM_001001557 48475061 M-033055-01 
EPDR1 54749  NM_017549 24475585 M-013378-01 
CDW52 1043  NM_001803 68342029 M-019509-01 
PRDM5 11107  NM_018699 41349475 M-020332-00 
NR0B1 190  NM_000475 5016089 M-003409-00 
ECM1 1893  NM_004425 12707564 M-011849-00 
SLC9A6 10479  NM_006359 110227627 M-007626-01 
SLC7A8 23428  NM_182728 33286429 M-007618-01 
LDHA 3939  NM_005566 5031856 M-008201-01 
TMEM88 92162  NM_203411 44662812 M-031924-00 
NPL 80896  NM_030769 13540532 M-008230-01 
 
Table 4.1: EMT Gene Signature Shared between Epithelial Stem Cells 
Developmentally Entering EMT and Claudin-low Breast Cancer. 
EMT gene signature identified from the combined analysis of intersecting gene array 
and RNA-seq data from epithelial stem cells described in Abell et al., Cell Stem Cell, 
2011, and the Claudin-low breast cancer subtype (Abell et al, 2011). 
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Figure 4.4: RNAi Screen Development 
(A) Acquisition of the epithelial phenotype by mesenchymal EpCAM(-) cells following 
siRNA-mediated knockdown of Snail, Slug or Snail/Slug genes as shown by 
immunostaining with nuclear DAPI stain, anti-E-cadherin and anti-EpCAM. (B) 
Elevated EpCAM and E-cadherin percent cellular fluorescence quantitated on a 
single cell basis following siRNA knockdown of indicated genes. Data represent the 
mean + range of 8 independent wells. (C) Elevated mRNA expression of epithelial 
markers EpCAM and E-cadherin following siRNA knockdown of Snail and Slug. Data 
represent the mean + the range of three independent experiments performed in 
triplicate.  
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Figure 4.5: FACS Separation of Mesenchymal EpCAM(-) and Epithelial 
EpCAM+/high Populations  
(A-B) Separation of EpCAM+/high and SUM149 EpCAM(-) cells by FACS shows less 
than 0.5 percent EpCAM+/high contamination of the EpCAM(-) cells. Data represents 
FACS analysis of three individual cell sorts used for confirming the RNAi screen. (C) 
Titration of known percentages of EpCAM+/high SUM149 cells into an EpCAM(-) 
background confirms accurate quantitation of the percent EpCAM and E-cadherin 
fluorescence on a single cell basis.  
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Figure 4.6: RNAi screen Identifies Genes Important for EMT. 
(A-B) Elevated EpCAM and E-cadherin percent cellular fluorescence quantitated on 
a single cell basis following siRNA-mediated knockdown of indicated genes. Data 
represent the mean + range of 6 independent wells from the primary screen. 
Statistical significance was evaluated by an unpaired Student’s T-test. ***p-value < 
0.001;     **p-value < 0.01. (C-D) Acquisition of the epithelial phenotype by 
mesenchymal EpCAM(-) cells following siRNA-mediated knockdown of indicated 
genes is shown by mmunostaining of (C) SUM149 and (D) SUM229 EpCAM(-) cells 
with nuclear DAPI stain, anti-E-cadherin and anti-EpCAM antibodies.  
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Figure 4.7: RNAi Screen Raw Images 
(A-C) Representative plate images from the RNAi screen showing expression of 
epithelial markers E-cadherin and EpCAM by immunofluorescence in EpCAM(-) 
SUM149 cells following siRNA-mediated knockdown of target genes in duplicate 
wells shown in columns 2-11, rows A-H; siGAPDH in columns 1 and 12, rows B-D 
and E-H, respectively; siSnail/Slug in columns 1 and 12, rows E-H and A-D, 
respectively; and siUBB in wells A1 and H12. Data is representative of duplicate 
RNAi screens for 140 genes performed in triplicate. 
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Figure 4.8: EMT-Regulatory Genes Affect Cellular Invasiveness and 
Expression of EMT-Inducing Transcription Factors.  
(A) Expression levels of EMT-regulatory genes in EpCAM+/high compared to  
EpCAM(-) cells shown by qRT-PCR. (B) Deconvolution of siRNA smart pools 
demonstrates knockdown of EMT-regulatory genes with at least two individual 
siRNA oligonucleotides per gene in SUM149 EpCAM(-) cells as shown by qRT-PCR. 
(C) Cellular invasiveness of SUM149 EpCAM(-) cells following siRNA-mediated 
knockdown of indicated EMT-regulatory genes. **p-value < 0.01; *p-value < 0.05. 
Data are the mean + range of two independent experiments performed in triplicate. 
(D-E) Expression changes of EMT-inducing transcription factors in SUM149 
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EpCAM(-) cells following siRNA knockdown of the indicated EMT-regulatory genes. 
Data are the mean + the range of at least two independent experiments performed in 
triplicate. 
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Gene Name Function 
Pathway/Interacting 
Proteins Physiology 
Smarcd3/  
Baf60c 
SWI/SNF 
chromatin 
remodeling 
factor 
Binds transcription factors 
(GATA4, Smad4) and nuclear 
receptors (RAR, PPAR, ER, 
PR, ROR) 
Defects in heart 
morphogenesis, outflow 
tract remodeling and 
abnormal cell differentiation 
in mice 
Ptprb/VE-
Ptp 
Receptor 
tyrosine 
phosphatase 
Regulates adherens junctions. 
Binds VE-cadherin and Tie2 
Failure to remodel vascular 
scaffold and defects in 
higher order branching in 
mice 
Fhl1 Zinc finger 
protein 
Localized to focal adhesions 
to promote cell spreading. 
Binds Smad proteins and 
regulates TGF-beta 
responsive transcription 
Human mutations induce 
cardio/skeletal myopathies. 
Expression observed 
strongly in developing heart 
outflow tract 
EphA4 Receptor 
tyrosine kinase 
Regulates adherens junction 
signaling 
Important in angiogenesis 
Met Receptor 
tyrosine kinase 
Regulates adherens junction 
signaling via crosstalk with 
EGFR to activate PI3K/AKT 
pathways 
Important in angiogenesis 
and cell spreading 
N-cadherin Cell-cell 
adhesion 
glycoprotein 
Regulates adherens junction 
signaling by interacting with 
Fn/FGFR1 to activate 
MAPK/ERK pathways 
Regulates gastrulation and 
neural crest migration 
Slug Transcription 
factor 
Directly represses the 
epithelial marker E-cadherin 
Functions during 
gastrulation and heart 
outflow tract remodeling 
ABR GEF/GAP Activates Rac/Cdc42 
GTPases 
Important role in vestibular 
morphogenesis 
Rnf130 E3 ubiquitin 
ligase 
Unknown Unknown 
RRAGD GTPase with 
Ras homology 
Unknown  Unknown 
 
Table 4.2: Functional Description of EMT-Regulatory Genes Identified in the 
RNAi screen.  
Table describes the known gene function of the ten EMT-regulatory genes identified 
in the RNAi screen. 
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Figure 4.9: Smarcd3/Baf60c is a Novel Regulator of EMT.  
(A) Smarcd3/Baf60c-expressing HMECs (D3-HMECs) gain a mesenchymal 
phenotype with loss of epithelial properties as shown by phase microscopy and 
immunostaining of EV- and D3-HMECs with nuclear DAPI stain, anti-E-cadherin 
anti-EpCAM, or anti-vimentin antibodies. (B) Loss of epithelial markers EpCAM and 
E-cadherin and gain of mesenchymal markers fibronectin and vimentin in D3-HMEC 
cells are shown by Western blot. (C) Elevated mRNA expression of EMT-inducing 
transcription factors Lef1 and Zeb2 and reduced expression of epithelial and cell 
adhesion markers in D3-HMECs. Data represent the mean + range of three 
independent experiments. (D) Different antigenic profiles in EV- versus D3-HMECs 
demonstrated by FACS analysis with epithelial differentiation markers anti-EpCAM 
(FITC) and anti-Cd49f (PE-Cy5) or cancer stem-like markers anti-Cd44 (APC) and 
anti-Cd24 (FITC). (A-B and D) Data are representative of at least two independent 
experiments. 
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Figure 4.10: Smarcd3/Baf60c Induces the Claudin-low Gene Signature.  
(A) Gene expression profiles of D3-HMECs cluster with the Claudin-low gene 
signature. Heat map compares expression of D3-HMECs, Slug-HMECs and Snail-
HMECs to the 9-cell line Claudin-low predictor. Red and green indicates upregulated 
and downregulated genes, respectively. (B) Venn diagram depicts shared genes 
between D3-, Slug- and Snail-HMECs compared to the Claudin-low predictor. (C) 
Claudin-low human tumors show the highest expression of D3-HMEC genes among 
breast cancer subtypes, as demonstrated by the mean expression of D3-, Slug- and 
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Snail-HMEC genes across the subtypes of breast cancer in the UNC337 data set. p-
values were calculated by comparing gene expression means across all subtypes 
using an ANOVA test. Each + symbol represents a distinct tumor sample within the 
data set. (D) Differentiation scores compare D3-, Slug- and Snail-HMECs relative to 
EV-HMECs showing the lowest differentiation propensity of D3-HMECs. p-value was 
calculated by comparing gene expression means across all breast epithelial cell 
lineages. 
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Figure 4.11: Phenotypic Comparison of Snail and Slug to Smarcd3-Induced 
EMT 
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(A) Venn diagram depicts shared genes between D3-, Slug- and/or Snail-HMEC 
cells. (B) Loss of the epithelial phenotype with gain of mesenchymal properties in 
D3-, Slug- and/or Snail-HMEC cells as shown by phase microscopy and 
immunostaining with nuclear DAPI stain, anti-E-cadherin and anti-EpCAM. (C) 
Reduced protein expression of epithelial markers EpCAM or E-cadherin and 
elevated protein expression of mesenchymal markers fibronectin and vimentin in 
Snail-, Slug- and D3-HMEC cells. (D) Elevated gene expression of mesenchymal 
markers N-cadherin, vimentin and Smarcd3/Baf60c in Snail-, Slug- and D3-HMECs. 
(E) Elevated gene expression of EMT-inducing transcription factors and reduced 
expression of epithelial cell-cell adhesion markers in Snail- and Slug-HMECs. (B-C) 
Data represent at least two independent experiments. (D-E) Data represent the 
mean + range of three independent experiments performed in triplicate. 
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Figure 4.12: SWI/SNF Complex Regulates Non-Canonical WNT Signaling 
through Epigenetic Activation of Wnt5a. 
(A) Elevated expression of Wnt5a and Tgfβ in D3-HMECs shown by qRT-PCR. Data 
are the mean + the range of two independent experiments performed in triplicate. (B) 
Activation of non-canonical WNT signaling with inhibition of canonical WNT signaling 
is shown by elevated phosphorylation of PKCβ and reduced nuclear (nuc) but not 
whole cell (wc) β-catenin protein expression. (C) Induced Brg1 protein expression 
with the expression of Smarcd3/Baf60c in HMECs. (D) Brg1 co-immunoprecipitates 
with FLAG-Smarcd3/Baf60c in HMECs. (E-G) Elevated Smarcd3/Baf60c, Brg1 and 
H3K4me3 at the promoters of indicated genes in D3-HMECs compared to EV-
HMEC cells as measured by ChIP-qRT-PCR. Data are the mean + the range of 
three independent experiments performed in duplicate. 
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Figure 4.13: Wnt5a Expression Correlates with the Mesenchymal Phenotype of 
EpCAM(-) Cells. 
(A) Elevated gene expression of Wnt5a in Slug-HMECs similar to D3-HMECs as 
shown by qRT-PCR. (B) Elevated gene expression of Wnt5a in EpCAM(-) compared 
to EpCAM+/high cells. (A-B) Data represent the mean + range of two independent 
experiments performed in triplicate. 
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Figure 4.14: Inhibition of Wnt5a Restores Epithelial Adherens Junctions.  
(A) siRNA-mediated knockdown of Wnt5a partially restores the epithelial phenotype 
of D3-HMECs as shown by phase microscopy. (B) siRNA-mediated knockdown of 
Wnt5a increases mRNA expression of epithelial and cell-cell adhesion markers, 
whereas expression of the EMT-inducing transcription factors and mesenchymal 
markers is unchanged. Data are the mean + the range of two independent 
experiments performed in triplicate. (C) Increased protein expression of EpCAM and 
E-cadherin with loss of PKCβ phosphorylation in D3-HMECs transfected with 
siWnt5a. (D) Reduced invasiveness through growth-factor reduced Matrigel of D3-
HMECs treated with siWnt5a or the Wnt5a blocking antibody compared to untreated 
D3-HMECs. Significance was evaluated by an unpaired Student’s T-test. ***p-value 
< 0.001; **p-value < 0.01. Data are the mean + the range of two independent 
experiments performed in triplicate. 
 
 
Chapter V  
Conclusion 
 
Summary 
 The studies described herein define the molecular and epigenetic 
mechanisms responsible for the induction of EMT in epithelial stem cells and Basal-
like and Claudin-low subtypes of triple negative breast cancer (TNBC). Trophoblast 
stem (TS) cells paused in the intermediate stages of EMT allowed the discovery of 
epigenetic mechanisms regulating EMT in trophoblasts and highlighted an EMT 
gene signature overlapping with Claudin-low TNBC. Using TSKI4 cells, we have 
shown that MAP3K4 regulates the activity of CBP and that acetylation of histones 
H2A/H2B is required to maintain the epithelial phenotype of TS cells. Loss of 
MAP3K4/CBP activity results in the acquisition of an intermediate EMT phenotype 
associated with simultaneous maintenance of stemness properties and an 
unrestricted trophoblast invasive potential. During both development and the 
progression of cancer, hyperinvasion resulting from uncontrolled EMT signaling 
events can be detrimental to survival. TS cells in the intermediate EMT state have 
proven to be a unique tool to define novel epigenetic reprogramming events and 
signaling pathways important for induction of the EMT program. 
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 To understand the parallel mechanisms regulating EMT and the 
hyperinvasion associated with cancer progression, we identified an intersecting EMT 
gene signature	   from analysis of microarray data shared by TSKI4 cells 
developmentally entering EMT and the Claudin-low subtype of TNBC. We designed 
a phenotypic RNAi screening strategy to define individual genes sufficient to 
promote the epithelial EpCAM+/high phenotype in a mesenchymal Claudin-low 
EpCAM(-) subpopulation of SUM149 and SUM229 breast cancer cells. Using this 
RNAi screening approach, the SWI/SNF chromatin-remodeling factor 
Smarcd3/Baf60c was identified as a novel epigenetic EMT-regulatory gene. RNAi 
silencing of Smarcd3/Baf60c in mesenchymal EpCAM(-) breast cancer cells 
promoted an epithelial phenotype, whereas expression of Smarcd3/Baf60c in 
HMECs was responsible for the Wnt5a-dependent induction of EMT. These results 
demonstrate that Smarcd3/Baf60c induces an EMT gene expression program in 
HMECs similar to that of the Claudin-low breast cancer subtype, suggesting that 
Smarcd3/Baf60c plays an important role in maintaining the EMT properties and 
mesenchymal morphology of these breast cancer cells. Due to the intersecting 
features of developmental and cancer EMT subtypes, a complete picture of this 
complex cellular program, which is fundamental to development and reactivated in 
adult tissues during disease progression, should be studied from multiple biological 
perspectives. 
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Significance and Future Directions 
Defined New Epigenetic Reprogramming Mechanisms for the Induction of EMT 
 EMT is a cellular reprogramming event responsible for the morphological and 
functional conversion of epithelial cells to the mesenchymal phenotype (Thiery et al, 
2009). Cells undergoing EMT maintain the same genomic background in both 
mesenchymal and epithelial states. However, during the progression of EMT, the 
gene expression profile significantly changes, as demonstrated by the repression of 
epithelial-specific genes and the activation of mesenchymal-specific genes (Nieto, 
2011). Without altering the primary DNA sequence, epigenetic mechanisms regulate 
gene expression levels by physically modifying DNA and/or its associated histone 
proteins. Epigenetic mechanisms including the acquisition of promoter specific DNA-
methylation, expression of miRNAs and the transcription factors Snail, Slug and 
Twist have been shown to induce EMT (Kouzarides, 2007; Nieto, 2002). Herein, we 
have defined epigenetic reprogramming factors controlling histone acetylation and 
chromatin remodeling as important for the induction of EMT. Specifically, we have 
demonstrated that the loss of acetylation on histones H2A/H2B and the increase in 
SWI/SNF chromatin-remodeling factors Smarcd3/Baf60c and Brg1 constitute two 
new epigenetic mechanisms important for the regulation of EMT. Rather than 
affecting the expression of a single gene, these epigenetic changes in H2A/H2B 
acetylation and SWI/SNF chromatin remodeling factors Smarcd3/Baf60c and Brg1 
affect a broad network of genes, which suppresses the epithelial phenotype and 
induces the mesenchymal phenotype.  
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 The role of histone acetylation and SWI/SNF chromatin-remodeling 
complexes in reprogramming events relevant to lineage commitment and the 
reversible processes of EMT and MET are not without precedent. Weinberg and 
colleagues have shown that the induction of EMT endows HMECs with stem cell-like 
properties, possibly suggesting a connection between the acquisition of epithelial 
plasticity and stemness properties (Mani et al, 2008; Morel et al, 2008). More 
recently, MET was shown to occur simultaneously with the reprogramming of 
fibroblasts to iPS cells, connecting the reprogramming events of the MET program to 
iPS cell generation and establishing MET is an intermediate event essential to 
generating iPS cells (Li et al, 2010). Signaling pathways such as TGFβ that are 
known to suppress MET reduce the efficiency of the iPS reprogramming process (Li 
et al, 2010; Plath & Lowry, 2011). Furthermore, each of the Yamanaka 
reprogramming factors makes a specific contribution toward the induction of MET. 
For example, OCT4 and SOX2 suppress Snail, KLF4 binds and activates E-
cadherin, and MYC reduces TGFβ signaling (Li et al, 2010). These studies 
demonstrate a connection between the reprogramming of somatic cells to iPS cells 
and the induction of MET and EMT programs.  
Epigenetic factors controlling histone acetylation and chromatin remodeling 
provide an additional link to the cellular reprogramming events relevant to iPS 
production. Proteomics studies reveal that SWI/SNF chromatin-remodeling BAF 
complex members Brg1 and Baf155 can enhance the reprogramming efficiency of 
somatic cells to induced pluripotent stem (iPS) cells by functionally replacing the 
transcription factor c-Myc (Singhal et al, 2010). Furthermore, in lineage commitment 
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events related to neural development, Smarcd3/Baf60c was identified with the 
acquisition of neural progenitor status (Lessard et al, 2007; Lessard & Crabtree, 
2010; Ho & Crabtree, 2010). During mouse development, loss of Smarcd3/Baf60c 
expression produces heart outflow tract defects, resulting from dysregulated EMT 
(Lickert et al, 2004). Our results demonstrated that Smarcd3/Baf60c induces an 
EMT gene expression program in HMECs similar to that of the Claudin-low breast 
cancer subtype, suggesting that Smarcd3/Baf60c plays an important role in 
maintaining the EMT properties and mesenchymal morphology of these cells. 
Additionally, we showed that Smarcd3/Baf60c is upregulated in a mesenchymal 
EpCAM(-) subpopulation of Basal-like breast cancer cells when compared to the 
epithelial EpCAM+/high population, indicating a negative role for the Smarcd/Baf60 
family in the progression to a more epithelial cell state. In support of this hypothesis, 
the SWI/SNF factors from the Smarcd/Baf60 family are silenced at high frequency in 
Luminal breast cancers, demonstrating the relevance of the Baf60 family to the 
inhibition of more differentiated epithelial breast cancers (Stephens et al, 2012). 
Conversely, studies linking the importance of histone acetylation to reprogramming 
demonstrate the requirement for precise temporal and spatial modulation of histone 
acetylation levels for improved iPS reprogramming efficiency. Treatment of 
fibroblasts with a narrow range of concentrations of histone deacetylase (HDAC) 
inhibitors Trichostatin A, sodium butyrate or valproic acid during reprogramming can 
enhance iPS reprogramming efficiency (Mali et al, 2010; Huangfu et al, 2008; Liang 
et al, 2010). Furthermore, genetic ablation of class I or II HDACs during mouse 
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knockout mouse for the class I HDAC3 is embryonic lethal due to gastrulation 
defects, suggesting that this critical developmental EMT event requires functional 
HDACs to proceed toward completion (Haberland et al, 2009). Collectively, these 
studies demonstrate the importance of precise modulation of histone acetylation and 
SWI/SNF chromatin-remodeling factors for the control of reprogramming events 
related to EMT and MET. 
 Future studies should focus on defining: 1) Additional epigenetic mechanisms 
contributing to changes in histone acetylation associated with the induction of EMT; 
and 2) Connections between the changes in histone acetylation and SWI/SNF 
chromatin-remodeling factors. Unpublished data from Dr. Amy Abell revealed that 
HDAC6 coordinately regulates the loss of acetylation on many of the same genes 
affected by the inhibition of MAP3K4/CBP activity. Based upon these results, we 
hypothesize that the histone acetylation landscape is modulated by multiple 
epigenetic factors and that the interplay of these factors is essential for establishing 
optimal histone acetylation levels for maintenance of the epithelial phenotype. An 
active area of research in the Johnson lab is to use ChIP-seq to identify genes 
coordinately regulated by CBP and HDAC6 in TS cells and to define how these 
genes regulate the epithelial phenotype. Furthermore, multiple reports describe 
crosstalk between histone acetylation marks and chromatin-remodeling complexes 
(Kouzarides, 2007; Jenuwein, 2001). For example, HATs and HDACs can recruit 
chromatin-remodeling machinery either directly through physical interactions or 
indirectly through modulation of the epigenetic landscape. Importantly, histone 
H2A/H2B dimer exchange is an important step in ATP-dependent SWI/SNF 
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chromatin-remodeling that can be mediated via histone acetylation (Ito et al, 2000). 
Alternatively, histone acetylation can also negatively impact the ATPase activity of 
the chromatin-remodeling machinery. Since EMT was induced by selective loss of 
H2A/H2B acetylation and the increase in expression of chromatin-remodeling factors 
Smarcd3/Baf60c and Brg1, we hypothesize that H2A/H2B acetylation and Smarcd3-
dependent SWI/SNF chromatin-remodeling occur sequentially, whereby changes in 
histone acetylation can promote chromatin-remodeling events. Future studies might 
examine the connection between loss of H2A/H2B acetylation and increased ATP-
dependent chromatin-remodeling factors Smarcd3/Baf60c and Brg1. Using TS cell 
models, TSKI4, TSshCBP and TSshHDAC6, we can examine the effect of selective loss of 
H2A/H2B acetylation on chromatin-remodeling by micrococcal nuclease digestion 
coupled to high throughput sequencing, enabling the study of nucleosome 
occupancy on a genome-wide scale. These studies could provide insight into the 
crosstalk between the epigenetic modulation of histone acetylation and SWI/SNF 
chromatin-remodeling events that induce EMT. 
Defined the Metastable Phenotype in Developmental EMT 
 The intermediate stage of EMT, coined the metastable phenotype, describes 
the simultaneous existence of both epithelial and mesenchymal characteristics and 
is of great importance for understanding the cellular changes associated with 
progression of the EMT program and maintenance of stem cell-like properties (Lee, 
2006). The metastable EMT phenotype is defined by enhanced cellular invasiveness 
with the coexistence of stem cell properties, making this intermediate stage of EMT 
particularly important to study with respect to cancer metastasis (Jordan et al, 2011). 
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Recent studies reveal that in the malignant progression of cancer, there exists a 
partial rather than a complete cellular morphology transition with the invading front of 
most metastatic tumors moving as epithelial sheets rather than as individual cells, 
suggesting the importance of the intermediate EMT state to cancer metastasis 
(Friedl & Wolf, 2003; Brabletz et al, 2005). Due to the tremendous difficulty in 
capturing cells in the intermediate states of EMT, most studies focus on the initiation 
or completion of EMT. To our knowledge, this is the first report that characterizes the 
intermediate stages of developmental EMT, using multiple TS cell models to track 
the metastable EMT continuum. Furthermore, the EpCAM(-) Basal-like SUM149 and 
SUM229 breast cancer cells capable of converting between mesenchymal and 
epithelial states might also represent a metastable EMT phenotype, since these cells 
are also characterized by enhanced cellular plasticity associated with the 
intermediate stage of EMT (Gupta et al, 2011; Proia et al, 2011). The EpCAM(-) 
SUM149 and SUM229 breast cancer cells have significant mesenchymal Claudin-
low features, but these cells do not profile as completely Claudin-low by gene array 
analysis, suggesting that they might be in an intermediate stage of EMT rather than 
fully mesenchymal.  
 The coexistence of EMT and stem cell properties makes the intermediate 
stage of EMT important to fully understand as a state distinctly different from the 
beginning epithelial or ending mesenchymal states typically studied. It is 
hypothesized that the intermediate stage of EMT is the only fully reversible point on 
the EMT continuum and therefore represents the point with greatest cellular 
plasticity and cellular invasiveness, attributing to the acquisition of enhanced stem-
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like and metastatic properties. Future studies should focus on further molecular 
characterization of the metastable EMT phenotype in both development and cancer. 
The following broad questions are important to address: 1) What are the molecular 
and epigenetic signaling pathways important for inducing the progression of the EMT 
continuum from epithelial to intermediate to mesenchymal stages; and 2) Do 
invasive cancer cells resemble the metastable phenotype characteristic of the 
intermediate stage of EMT? Using TS cell models, including TSKI4, TSshCBP, TSSnail 
cells, to represent the developmental EMT program and Basal-like breast cancer 
cells simultaneously expressing mesenchymal EpCAM(-) and epithelial EpCAM+/high 
states to represent the breast cancer EMT program, we can examine the signaling 
pathways controlling the progression of EMT. Since the TS cell models indicate the 
importance of kinase signaling in promoting the epigenetic changes associated with 
the metastable EMT phenotype, we would initially examine the connections between 
broader kinase signaling networks and the intermediate EMT state using the 
multiplexed inhibitor bead/mass spectrometry (MIB/MS) technology developed in the 
Johnson lab (Duncan et al, 2012). Following, in vitro, studies with our cell culture 
systems, we could extend these experiments to human-in-mouse tumors exhibiting 
morphologically distinct features similar to Basal-like SUM149 and SUM229 breast 
cancer cells. Collectively, these studies might provide insight into the connections 
between the metastable EMT phenotype and the metastatic progression of cancer. It 
is our hypothesis that cancer cells become metastatic upon reaching the 
intermediate stage of EMT.  
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Identified Genes Sufficient to Induce EMT in Development and Breast Cancer 
 EMT has largely been studied from the singular perspective of individual 
model systems, including chick and frog models of neural crest development, fibrotic 
kidney cell lines, metastatic cancer cell lines, fibroblasts or epithelial cell lines 
transduced with factors such as TGFβ, Snail or Twist (Yang & Weinberg, 2008; 
Thiery et al, 2009). To our knowledge, the studies described herein are the first to 
examine EMT from two distinct biological perspectives and EMT subtypes. From the 
analysis of gene array data, we identified a statistically significant intersecting EMT 
gene signature	   shared by epithelial stem cells developmentally entering EMT and 
the Claudin-low subtype of TNBC (Abell et al, 2011). Using SUM149 and SUM229 
Basal-like breast cancer cells, we designed a phenotypic RNAi screening strategy to 
identify individual genes sufficient to promote the EpCAM+/high epithelial phenotype in 
the mesenchymal Claudin-low EpCAM(-) population of breast cancer cells. These 
results demonstrate that parallel mechanisms control EMT during development and 
breast cancer. 
 In addition to Smarcd3/Baf60c, the phenotypic RNAi screen identified nine 
additional genes sufficient to promote the EpCAM+/high epithelial phenotype in the 
mesenchymal Claudin-low EpCAM(-) population of breast cancer cells. With the 
exception of Slug, N-cadherin, and the receptor tyrosine kinase Met, the remaining 
genes are uncharacterized with respect to EMT. Therefore, future studies should 
examine the underlying mechanisms contributing to EMT by molecular 
characterization of the undefined EMT-regulatory genes identified in the RNAi 
screen. Among these uncharacterized EMT-regulatory genes, Rnf130 and Fhl1 are 
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interesting genes to initially study. Rnf130 is a putative E3 ubiquitin ligase 
preferentially expressed in the mesoderm during development (Guais et al, 2006). It 
is hypothesized that Rnf130 may regulate apoptosis in hematopoietic cells, but its 
function is largely unknown. Preliminary findings from our group have demonstrated 
that combined knockdown of Rnf130, Slug and Smarcd3/Baf60c produced subtle 
synergistic effects in promoting an epithelial morphology in fully mesenchymal 
Claudin-low SUM159 breast cancer cells. These results indicate that Rnf130, Slug 
and Smarcd3 might be part of a common EMT-regulatory signaling network. 
Additionally, Fhl1 is another gene identified in the EMT-regulatory RNAi screen. Fhl1 
is a zinc finger protein that localizes to focal adhesions to promote cell spreading 
and binds Smad proteins to promote TGFβ-responsive transcription (Rafael et al, 
2012; Sheikh et al, 2008; Ding et al, 2009). Furthermore, the closely-related family 
member Fhl2 has been directly connected to EpCAM expression through direct 
interaction with the intercellular domain of EpCAM (Maetzel et al, 2009). Lastly, in 
TSKI4 cells, we have shown knockdown of Fhl1 to be capable of reversing the 
mesenchymal phenotype. Therefore, Rnf130 and Fhl1 are ideal gene candidates to 
mechanistically study with respect to EMT. 
Demonstrated the Reversible Nature of EMT in Breast Cancer 
 While it has long been accepted that EMT is a reversible process during 
development, few studies have examined the opposite process of mesenchymal-
epithelial transition (MET) in the progression of breast cancer. In addition to 
identifying ten genes important for regulating the phenotypic transitions between 
mesenchymal and epithelial cellular morphologies in breast cancer, the phenotypic 
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RNAi screening approach described herein highlights the reversible nature of EMT 
and MET in SUM149 and SUM229 breast cancer cells. To date, EMT is accepted as 
a morphological program controlling tumor cell invasion into the surrounding stroma 
and intravasation into the bloodstream (Valastyan & Weinberg, 2011). Although it is 
hypothesized that MET controls metastatic colonization of invasive tumor cells to 
distant organs, the process of MET has not been definitively connected with cancer 
metastasis. In support of this hypothesis, unpublished work from Dr. Aleix Prat 
demonstrates that injection of mesenchymal EpCAM(-) SUM149 and SUM229 cells 
into the mammary fat pads of immunocompromised mice resulted in the formation of 
EpCAM+/high epithelial tumors, possibly suggesting that the mesenchymal EpCAM(-) 
population converts to an epithelial EpCAM+/high population for tumor formation 
(unpublished data from A. Prat). 
 Therefore, future studies should focus on understanding the role of MET in 
the metastatic progression of cancer. Currently, it is hypothesized that the primary 
tumor and secondary metastatic tumor are fully epithelial, while the tumor cells 
invading into the surrounding stroma and the circulating tumor cells (CTCs) are 
mesenchymal (Rhim et al, 2012; Yu et al, 2012). Using xenograft mouse models and 
metastatic breast cancer cells transduced with epithelial- and mesenchymal-specific 
fluorescent reporter genes, we could track the processes of EMT and MET during 
the, in vivo, progression of breast cancer. With this model system, we could examine 
the primary tumor, CTCs and the secondary metastasis for the presence of epithelial 
or mesenchymal markers in conjunction with fluorescent reporter expression. 
Alternatively, we could use human-in-mouse tumor models to study the epithelial 
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and/or mesenchymal nature of the primary tumor, CTCs and the secondary 
metastasis by marker analysis. By understanding the role of EMT and MET in the 
progression of cancer, we can begin to develop treatment strategies for cancer 
metastasis using our knowledge of the cellular signaling pathways controlling these 
programs. 
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